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Neurons of mammalian nervous (CNS) fail to regenerate their 
axons after injury, leading to permanent of function. In contrast, axotomised 
CNS neurons in fish, amphibians and some can perform functional 
axon regeneration after injury. Generally, contributing to success or 
failure of axon regeneration lie in the intrinsic of injured neurons, as well 
as the surrounding microenvironment of the axon. Mammalian neurons 
may lack the intrinsic ability to survive after trauma, or to re-t9xr:lre~~s 1"1,"' .... "''''' 
for axonal regrowth. Moreover, several inhibitory to growth, such 
as Tenascin-R (TN-R) and Nogo-A, have been identified in 
proteins are associated with oligodendrocytes and 
major inhibitory components of the CNS microenvironment. 
are 
Anuran amphibians, e.g. Xenopus, a particularly model for 
axon regeneration: in tadpoles, the nerve (ON) spinal cord (SC) are 
regenerating successfully, while axon only occurs in ON, but not 
the of frogs after metamorphosis. In this study, distribution functional 
a"LJ~vl" of TN-R and Nogo-A were analysed in Xenopus frogs tadpoles by 
means of immunological detection methods and in vitro functional 2":'':2\,''': 
Western blots and immunohistochemical results revealed Nogo-A TN-R 
are present in tadpole as well as post-metamorphic Xenopus ON and 
Using double-labelling techniques with cell-type specific marker antibodies, 
proteins were found to be associated with oligodendrocytes and as 










axons and somata non-myelinated neurons throughout the CNS, it was 
particularly prominent during development, as well in peripheral nervous tissues 
thus diverging from the findings in mammals. cell-type expression 
of TN-R and Nogo-A were confirmed by immunocytochemical 
obtained from Xenopus neuronal Therefore, no correlation 
exists between levels of TN-R and Nogo-A expression on the one hand, and 
success in the different parts and developmental stages the 
Xenopus CNS on the other. 
Analysis of the 
down-regulation of either 
expression of TN-R and Nogo-A revealed no 
thus excluding possibility that reduced levels 
or absence of 
for 
growth inhibitors following injury could account 
axon l"r::>rlr::>n,r::>I"~ltll"1.n in Xenopus. 
In vitro functional using purified TN-R or Nogo-A proteins showed that the 
mammalian homologues of these proteins are poor for the growth of 
Xenopus neurons - demonstrating that the pathways mediating growth 
inhibition by and Nogo-A are conserved. However, it is not possible state 
currently whether Xenopus TN-R and Nogo-A are as inhibitory as their mammalian 
counterparts. Moreover, might in the sensitivity 
Xenopus neurons neurite growth inhibitors and influence their regenerative 
























Chapter 1 Introduction: Central Nervous System Regeneration 
1.1 General Introduction 
The central nervous system (CNS) integrates and 
coordinates all nervous impulses from the body, as well 
as all irnpulses following stimuli originating outside the 
body. This complex function requires a highly organized 
and sophisticated structure. In higher vertebrates, 
damage of this structure leads to irreversible loss of 
functions due to its limited capability to regenerate. On 
the clinical level, the impaired CNS could lead to paraplegia or blindness, if the 
injury occurs in spinal cord (SC) or optic nerve (ON) respectively. 
In the peripheral nervous system (PNS), the axonal injury leads to the Wallerian 
degeneration, which is a series rapid breakdown and phagocytosis of the 
nervous tissue and myelin sheath by macrophages and Schwann cells. 
Following Wallerian degeneration, Schwann cells in the distal nerve stump de-
differentiate, proliferate, align and express molecules to guide and promote 
axonal regeneration . Different phases can be distinguished in the regenerative 
response: sprouting of the proximal axon stump, axon elongation, target 
innervations and reformation of functional synapses (Fig. 1.1A). 
However, CNS responds differently to injury (Fig . 1.18). Degenerated tissue is 
removed mostly and slowly by the endogenous microglia. The microglia then 
become activated to form macrophages that are responsible for the phagocytosis 
of the debris. Following degeneration, the axonal regeneration in the CNS is 
mechanically and physiologically unfavorable. 
The reasons for the difference between CNS and PNS regenerative abilities in 
mammals could be (i) due to changes in the glial environment, or (ii) changes in 
the neurons and axons themselves, which make them unable to react to injury 
with a substantial regenerative response. Thus, identifying the factors that 

































Figure 1.1. Schematic diagram representing the main cellular reactions in the 
events of PNS and CNS injury. (A) In the PNS, after injury, there is sprouting from 
the proximal axon stump, and the Schwann cells lines up forming channels at the 
distal nerve stump. Guided by Schwann cells, the regenerating axons reach the 
effecter organ and reconnect the synapses, thus complete the regeneration process. 
(8) In the CNS, active astrocytes invade the site of injury and form a dense scar. 












Chapter 1 Introduction: Central Nervous System Regeneration 
1.2 Factors Contributing to the Axonal Regeneration 
A eNS lesion triggers metabolic and morphological changes in the axotomized 
neurons and their immediate or subsequent surrounding microenvironment. 
However, before axonal regeneration can commence, the injured neurons must 
first be able to survive after lesion. The intrinsic ability of neuronal growth should 
then be re-established during development. Secondly after regeneration 
commences, the extrinsic factors in the surrounding environment can alter the 
result of regeneration in such a way that when a favorable substrate is provided, 
growing axons can elongate through an obstacle-free environment. Lastly, the 
guidance cues are crucial to the growth cone pathfinding and making appropriate 
contact with their targets so the functional connection can be restored (for 
reviews, see Bregman, 1998; Schwab and Bartholdi, 1996). 
Accordingly, the following factors are likely to be the major influences on the 
axonal regenerating capacity: (i) neuronal survival, (ii) intrinsic property of axon 
growth, (iii) extrinsic environmental factors, and (iv) the molecular guidance of 
axon outgrowth. 
1.2.1 Neuronal Survival 
In the lesioned eNS, necrosis can lead to massive neuronal death. The initial 
wave of necrotic cell death may be followed by a wave of apoptotic cell death. 
Apoptosis, or programmed cell death plays a key role in the developing nervous 
system, and also contributes to cell death after eNS injury (Liu et aI., 1997). 
Apoptotic cell death is mediated by either gene expression or regulation of 
proteins already present in the cell, such as the pro and anti- apoptotic proteins. 
The injured neurons after axotomy can be protected from the apoptotic death by 
the expression of anti-apoptotic proteins, such as Bcl-2 (Bonfanti et aI., 1996). 
However, the anti-apoptotic activity of Bcl-2 may be altered by proteins other 
than known apoptotic regulators. For example, overexpression of Nogo-B (also 











Chapter 1 Introduction: Centrai Nervous System Regeneration 
members on the endoplasmic reticulum membrane, thereby reducing their anti-
apoptotic function (Li et aI., 2001). 
The survival of neurons also depends on the continuous inhibition of apoptosis 
by trophic signals from the environment. During development, neurons compete 
for substances called neurotrophic factors that are supplied by target cells. The 
nerve cells that do not make proper connections with the target cells die by 
apoptosis (for review, see Goldberg and Barres, 2000; Bahr, 2000). 
In addition, Schwann cells are capable of secreting a variety of neurotrophic 
factors to promote neuronal survival after PNS injury (for review, see Goldberg 
and Barres, 2000). However, it is uncertain whether CNS glia playa similar role 
to promote the survival of an injured neuron. Thus, blocking intrinsic cell suicide 
programs by the supply of neurotrophic stimuli might allow some cells to survive 
the initial trauma of CNS injury. In fact, studies have indicated that neurotrophic 
factors play a role in helping the survival of injured CNS by preventing the 
atrophy ofaxotomized neurons, and consequently enhancing the ability to 
regenerate (Kobayashi et aI., 1997; for review, see Goldberg and Barres, 2000). 
1.2.2 Intrinsic Property of Axonal Growth 
Successful axonal regeneration requires axon growth. The axotomized neurons 
need to be induced or signaled to extend their axons by the re-expression of 
proteins, which are responsible for the formation of neural network in embryonic 
and early post-natal life. Several molecules present during development have 
been identified and shown to govern the neuronal regenerative response to 
axotomy. Within these molecules, a number of cell surface proteins directly 
mediate interactions with others in the surrounding environment of the axon, 
such as growth-associated protein 43kD (GAP-43) and a variety of cell adhesion 
molecules (CAMs). 
Although the function of GAP-43 is poorly understood at present, the expression 











Chapter 1 Introduction Central Nervous System Regeneration 
expressed in PNS neurons as well as in the developing CNS. Therefore, GAP-43 
is a well known marker of axonal growth. In response to axonal lesions, re-
expression of high GAP-43 levels that correlated with successful regeneration 
was observed (Becker et aI., 1998). Stimulation or overexpression of GAP-43 
expression at the lesion site promoted axonal sprouting and regeneration (Aigner 
et aI., 1995; Kobayashi et aI., 1997). 
Another example of growth-associated surface proteins is a 
group of cell adhesion molecules (CAMs) of immunoglobulin 
superfamily (lgSF). These CAMs capable of both homophilic 




binding to other 
molecules 
development of the PNS and CNS. They function in axon outgrowth, elongation 
and fasciculation. The expressions of cell adhesion molecules such as NCAM 
(neural cell adhesion molecule), L 1 and N-cadherin have been shown to 
correlate with axonal growth after axotomy (Becker et aI., 1998; Roonprapunt et 
aI., 2003). Among these CAMs, L 1 in particularly, can stimulate neurite outgrowth 
in culture and promote axon regeneration after spinal cord injury (Roonprapunt et 
aI., 2003). 
There are also intracellular molecules that affect the processes of growth cone 
advance and axon motility, such as the cytoskeletal proteins as well as the 
intracellular machinery involved in the signaling pathways of axonal growth. Most 
of the cytoskeletal proteins observed during axonogenesis are re-expressed 
during axon regeneration, for instance Ta1, a tubulin isoform (Kobayashi et aI., 
1997; Miller et aI., 1989). Members of Rho family of small guanosine 
triphosphatases (GTPases) are also of importance in the transduction of 
extracellular signals into changes in the cytoskeleton. Manipulating the activity 
state of Rho and its effectors may either inhibit or promote neurite outgrowth 
(Fournier et aI., 2003). High level of the second messenger, cAMP (cyclic AMP), 












Chapter 1 Introduction: Central Nervous System Regeneration 
1.2.3 Extrinsic Factors in the Environment 
In higher vertebrates, the injured CNS axons are irreversibly impaired due to the 
lack of successful regeneration. In contrast, PNS axons regenerate well. 
Increasing evidence suggests that there are differences in the PNS and CNS 
environment in which axons are located. Generally, the extrinsic environmental 
factors contributing to the different regenerative capacities lie in the surrounding 
glial environment and extracellular matrix (ECM) of transected axons (for review, 
see Fawcett and Asher, 1999). 
The glial cells (originated from the word "nerve glue") surrounding the neurons in 
the CNS environment, were termed in 1859 by Rudolph Virchow, who believed 
glia to be a passive supporting tissue that held the neurons together. In the late 
19th century, Cajal employed metallic staining techniques, which revealed the 
different types of glia in the CNS: astrocytes, 
oligodendrocytes, microglia and ependymal cells. In the 
PNS, the major glial component is Schwann cell 
(Zigmond et aI. , 1999). As the biotechnology has 
advanced, new findings have changed the understanding 
of glial cells. Glial cells are found no longer to be inactive 
supporting cells; rather they are active participants in 
Santiago Ram6n y 
Caja/ (1852-1934) is 
considered to be 
the great pioneer of 
neuroscience. He 
was awarded Nobel 
Prize for Medicine 
in 1906. 
many nervous functions under physiological and pathological conditions (for 
reviews, see Fawcett and Asher, 1999; Fields and Stevens-Graham, 2002). 
The ECM is an intricate network composed of a variety of proteins and 
polysaccharides that are secreted and organized into a meshwork in extracellular 
spaces, in close association with the local cells. The cells produce all the ECM 
molecules and are at the same time influenced by them. The matrix plays a 
complex role in regulating cellular behavior, such as proliferation and migration. 
Thus, variations in different types of ECM molecules and organization give rise to 
a vast diversity of forms to meet the functional requirements of the particular 
tissue (Zigmond et aI., 1999). In the CNS, the ECM contains several types of 











Chapter 1 Introduction Central Nervous System Regeneration 
neurons and glia interact. Many ECM molecules have been identified along 
axonal pathways during development or after lesion in the nervous system that 
may have axon growth promoting or axon growth inhibitory effects (Zigmond et 
aI., 1999). 
When the CNS environment is replaced by that of peripheral nerves at the 
transected CNS, the axons from the injured neurons can elongate into the 
peripheral nerve grafts. Although the regenerating neurites eventually bridge the 
injury site, function is not restored because the neurites stop growing after re-
entering the CNS environment (David and Aguayo, 1981; Benfey and Aguayo, 
1981). 
It has been established that in the mammalian CNS microenvironment that 
oligodendrocytes, the myelin sheaths formed by oligodendrocytes and the glial 
scar formed by reactive astrocytes at the site of a CNS lesion can prevent axon 
growth (Fig. 1.2). This is achieved by exposing potent neurite outgrowth 
inhibitors or depositing inhibitory ECM molecules at the site of injury that prevent 
axon growth (Davies et aI., 1997; Liuzzi and Lasek, 1987; Schwab and Caroni, 
1988). More details on neurite outgrowth inhibitors are shown below. 
1.2.4 Molecular Guidance of Axon Outgrowth 
One of the aspects considered in axonal regeneration is whether the re-growing 
axons can find their targets and establish functionally meaningful connections. 
During development, the pathfinding mechanism of nerve growth ensures that 
growing axons can elongate along "specific" pathway and innervate appropriate 
targets. The axon pathfinding depends on the guidance cues, which serve either 
as attractants or repellents, thereby resulting different types of axonal behavior 
(for review, see Stoeckli et aI., 1998). The growth cone receptors, acting as 
sensors, can detect and navigate toward or away from the source of substrate-
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Figure 1.2. Schematic diagram representing the microenvironment at the site of 
lesioned CNS axon. Following injury, a regenerating axon will encounter neurite 
outgrowth inhibitors which are associated with oligodendrocytes and myelin sheath. 
The glial scar is not only a mechanical barrier, also contains inhibitory molecules that 
can inhibit axonal extension. In general, these are believed to be the extrinsic factors 
in the surrounding environment ofaxotomized axon contributing to the failure of CNS 
regeneration. (Adapted from Spencer et aI., 2003) 
The netrins are a group of guidance cues for developing axons. In vitro studies 
showed neurites from the Xenopus and mouse embryonic retinal ganglion cell 
(RGC) exhibit a chemoattractive response toward a point of netrin-1 source, 
mediated by the receptor DCC (de la Torre et aI., 1997). At the optic disc of the 
developing eye, null expression of netrin-1 disorientates the pathfinding of RGC 
axon, leads to optic nerve hypoplasia (Deiner et aI., 1997). In the injured optiC 
nerve of fish, the coordinated expression of netrin-1 and its receptors correlates 
with the successful regeneration (Petrausch et aI., 2000). In addition, netrin-1 
promote neurite outgrowth from embryonic mouse retinal explants in a dose 
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Growh Cone 
~,....,..,.-+-- Guide Cell 2 
Target Tissues 
/" " 
Guide Cell 2 
I 
' ''~\ ~
Guide Cell 3 ~~ 
Figure 1.3. Schematic diagram representing the effects of environmental cues on 
axon guidance. The growth cone of the axon is attracted by the secretion of guide 
cell 1, but is repelled by the guide cell 2. Eventually the growth cone passes through 
guide cell 3 and reaches its target tissues. 
(Adapted from http://web.sfn.org/contenUPublications/BrainBriefings/axon.html) 
The large semaphorins family, including secreted, transmembrane and GPI-
linked proteins, has been strongly associated with axon guidance. Similarly, a 
variety of ephrins and their Eph receptors have been implicated in guiding axons 
and topographic mapping. These molecules are involved in the formation of axon 
projections during nervous system development, acting through bidirectional 
signalling (for reviews, see Cook et al., 1998; Holland et aI., 1998). Furthermore, 
they are capable of inducing growth cone collapse. The upregulation of these 
molecules after injury have implicated their role of neurite outgrowth inhibition 
that contributes to the unfavourable environment for axonal regeneration 
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1.3 Neurite Outgrowth Inhibitors 
Differentiated oligodendrocytes in culture and CNS myelin exert a strong 
inhibitory effect on adhesion and outgrowth for primary neurons as well as 
spreading of non-neuronal cells (Caroni and Schwab 1988; Mckerracher et aI., 
1994). It is further known that growth cones interacting with differentiated 
oligodendrocytes could not extend across these cells and growth cone collapse 
was induced in contact with the surface of oligodendrocytes (Fawcett et aI., 1989; 
Lang et ai, 1996). In addition to those surface expressed inhibitory molecules, 
there are others in the surrounding ECM, especially at the site of injury. 
The search for oligodendrocyte and myelin associated neurite growth inhibitors 
has led to the characterization and identification of several activities and 
molecules such as myelin-associated glycoprotein (MAG) (Mckerracher et aI., 
1994; Mukhopadhyay et aI., 1994), oligodendrocyte myelin glycoprotein (OMgp) 
(Wang et ai, 2002b), chondroitin sulfate proteoglycans (CSPGs) (Nieder6st et aI., 
1999), tenascin-R (Pesheva et aI., 1989; Rathjen et aI., 1991) and Nogo-A 
(Caroni and Schwab, 1988; Chen et aI., 2000). In the present study, the 
emphasis is placed on two of the neurite outgrowth inhibitors; tenascin-R (TN-R), 
a cell surface ECM glycoprotein; and Nogo-A, an oligodendrocyte and myelin 
associated inhibitor. 
1.3.1 Tenascin-R 
Most of the ECM proteins, which consist of multidomain glycoproteins as the 
structural basis, are involved in a variety of cellular interactions. Some proteins 
have both cell adhesive and anti-adhesive properties, while some have both 
neurite inhibitory and promoting effects within the same protein. TN-R is a 
typical example of such a multipurpose molecule (for reviews, see Pesheva and 
Probstmeier, 2000; Pesheva et aI., 2001). 
TN-R belongs to the tenascin family of ECM glycoproteins. This family comprises 










































Chapter 1 Introduction: Central Nervous System Regeneration 
called janusin (in rodents) and restrictin (in chicken). The predicted amino acids 
sequences of chicken and rat TN·-R show a homology of more than 80% (Fuss et 
aI., 1993; Pesheva et aI., 1989; Rathjen et aI., 1991). TN-R protein is also found 
in the lower vertebrates, such as amphibians and fish, whose predicted amino 
acids sequence is -60% to those of TN-R in amniotes (Becker et aI., 1999, 2003). 
In the CNS, TN-R proteins are predominately expressed by 0-2A linage cells 
(oligodendrocyte and type-2 astrocyte), and are most abundant during the period 
of myelination. The expression of TN-R was mostly associated with the surface 
of oligodendrocytes, myelinated axons and Nodes of Ranvier (Fuss et aI., 1993; 
Norenberg et aI., 1996; Pesheva et aI., 1989: Rathjen et aI., 1991). It has been 
shown to accumulate in perineuronal nets of interneurons and motoneurons, of 
which is often found in a co-expression with TN-C or CSPG (Angelov et aI., 1998; 
Bruckner et aI., 2003; Xiao et aI., 1997). Apart from the CNS tissue, TN-R is 
transiently expressed by Schwann cells during PNS development (Probstmeier 
et aI., 2001). 
Many in vitro studies have clearly demonstrated the neurite outgrowth inhibitory 
effects of TN-R on different population of neuronal explants (Fig . 1.5) (Becker 
C.G. et aI., 1999, 2004; Becker T. et aI., 2000; Probstmeier et aI., 2000a) . The 
repulsive property of TN-R on neurite outgrowth is mediated by a neuron-specific 
immunoglobulin superfamily glycoprotein F3/11/contactin (Probstmeier et aI., 
2000b), which anchors on the cell surface membrane by glycosylphosphatidyl-
inositol (GPI) linkage and is implicated in axonal growth and synaptogenesis (For 
review, see Falk et aI., 2002). In the context of inhibitory substrate, TN-R was 
investigated as a neurite outgrowth inhibitor in part of CNS axonal regeneration. 
It is believed that the continued expression of TN-R protein after CNS injury 
contributes to the failure of axonal regeneration in mammal (Becker et aI., 2000; 
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TN-R I 
Substrate 
Figure 1.5. Schematic diagram representing the neurite outgrowth inhibition of TN-R. 
In the in vitro substrate border assay, the neurites are allowed to exit the neuronal 
explants on the favourable substrate, such as poly-lysine or lam in in. When the 
neurites grow into a sharp border of TN-R protein, neurites steered away and 
avoided the border. 
1.3.2 Nogo-A 
Initially, Caroni and Schwab were testing the nonpermissive components for 
neurite extension in the optic nerve of rats. The neurite growth and fibroblast 
spreading assay revealed that an important part of the neurite outgrowth 
inhibition was exerted in membranes of differentiated oligodendrocyte and in 
CNS myelin (Caroni and Schwab, 1988; Schwab and Caroni, 1988). Two 
inhibitory protein fractions of 35 kD and 250 kD were recovered from 
electrophoresis gel, and identified as neurite growth inhibitors NI-35/250 by their 
molecular weights (Caroni and Schwab, 1988). A monoclonal antibody, mAB IN-
1 (for inhibitory neutralization), raised against myelin fraction was able to reduce 
the myelin-derived inhibitory activity in vitro (Chen et aI., 2000; Lang et aI., 1995). 
The administration of IN-1 antibody after SC lesion of rats could neutralize 
myelin-associated neurite outgrowth inhibitors, and enhance axonal regeneration 
leading to some degree of functional recovery (Bregman et aI., 1995: BrOsamle 
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The bovine homologue of rat NI-2S0, bNI-220, was purified by biochemical 
characterization. Purified bNI-220 exhibited potent neurite outgrowth inhibitory 
activity that could be fully neutralized by the mAS IN-1 (Spillmann et aL , 1998). 
Results of microsequencing of bNI220 protein were used to screen cDNA 
libraries and databases, led to the isolation of nogo gene. The protein products 
of this nogo gene, Nogo-A, -S and -C resulted from both alternative splicing and 
promoter usage and showed strong C-terminal homology to reticulon (Rtn) 
protein family (Fig . 1.6) (Chen et aL, 2000; GrandPre et aL, 2000; Prinjha et aL, 
2000). Since the identification of Nogo/Rtn4, most of the Rtn researcher have set 
emphasis on Nogo-AlRtn4-A which corresponds to NI-2S0 (for review, see Oertle 
and Schwab, 2003). 
Expression analysis of Nogo-A revealed Nogo-A is highly expressed in 
oligodendrocytes, myelin and various types of neurons (Huber et aL, 2002; Hunt 
et aL , 2003; O'Neill et aL, 2004; Taketomi et aL, 2002; Tozaki et aI., 2002). The 
application of mAS IN-1 and the antisera generated against different peptide 
sequences of Nogo-A have been shown to neutralize the activity of the myelin-
derived inhibitory proteins in several in vitro bioassays, such as cell spreading 
and dorsal root ganglion (DRG) or RGC neurite outgrowth assay (Chen et aL, 
2000; Oertle et aL, 2003b). The structural and functional studies suggest that the 
regions of Nogo-A exert these nonpermissive effects lie in both Nogo-A specific 
N-terminal domain and the C-terminal 66-amino acid loop (Nogo-66) within the 
two putative transmembrane domains (Fig. 1.6) (Fournier et aL , 2001; Oertle et 
aL, 2003). Furthermore, the inhibitory N-terminal was shown to exhibit two 
different active sites: a region involved in fibroblast spreading, and a stretch 
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Gene-speclflc N-terminl RHO 
N- -c RTN1-A 




Nogo-A specific region Nogo-66 
~ ......... ~ ....... -








Figure 1.6. The sequence structures of Nogo/Rtn-4 and other paralogues of the Rtn 
proteins. Rtn family members share the homology of C-terminus, called reticulon-
homology domain (RHD), consisting of two putative transmembrane (TM) domains. 
Both Nogo-66 and the Nogo-A specific N-terminus of Nogo-AlRtn4-A were shown to 
be inhibitory. (Adapted from Oertle and Schwab, 2003) 
1.3.2.1 Nogo-66 Receptor 
Although the identity of the binding receptors for Nogo-A specific N-terminus is 
still not clear, the Nogo-66 receptor (NgR) has been identified and shown to 
express in neurons and axons (Fournier et aI., 2001; Wang et aI., 2002). The 
predicted protein contains a conventional N-terminal signal sequence followed by 
leucine-rich-repeat (LRR) domains, and an LRR C-terminal (LRRCT) motif that is 
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1.4 Regeneration in Lower Vertebrates 
In the CNS of mammals and birds, the poor regeneration capacity after an injury 
is well recognized. In contrast, regeneration of injured CNS axon occurs in the 
lower vertebrates, such as 'fish, urodeles and anurans (Gaze, 1970). The 
underlying mechanisms and differences are not yet fully understood. However, 
extensive behavioral recovery and axonal growth across spinal cord (SC) and 
optic nerve (ON) lesions in fish and certain amphibians have been studied and 
observed in many post-lesion studies. 
Transection of the ON in goldfish is followed by a high degree of axonal 
regeneration. One of the factors that contributes to the successful regeneration is 
the growth cone of regrowing RGC which is capable of making contacts with the 
myelin and glial scar, thus successfully reestablishing the visual pathway (Strobel 
and Stuermer, 1994). In the urodele amphibian animal models, lesioned SC can 
be regenerated completely even in adulthood. However, there is not yet any 
evidence for such successful regeneration. There are only indications supporting 
this regeneration process, such as retention of embryonic character and the 
response of ependymal glia (for review, see Chemoff et aI., 2003). 
In anurans, the cellular substrate, like ependymal processes, was suggested to 
be supportive for the axonal regeneration of the Xenopus tadpole SC (Michel 
and Reier, 1979). Reier proposed that the regenerating ON of Xenopus tadpole 
was able to ignore the mechanical barrier formed by glial scar, and penetrate 
through it (Reier, 1979). Further studies showed regeneration of fiber tracts in the 
injured SC does occur in the larval tadpole stage, but not after metamorphosis 
(Beattie et aI., 1990). However, ON regeneration is possible in both tadpole and 
adult frogs (Gaze et aI., 1990; Reier, 1979). Thus, different C NS regeneration 
capacities in anuran, which are dependent on the metamorphosis, make it a 
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1.4.1 Expression of Neurite Inhibitors in Lower vertebrate 
Early results suggest that the absence or low expression of neurite outgrowth 
inhibitory proteins in the CNS of lower vertebrates plays a major role in the 
success of axonal regeneration (for review, see Bernhardt, 1999). However, 
tenascins (Fuss et aI., 1993; Pesheva et aI., 1989; Rathjen et al ., 1991) and 
Nogo/RTN4 (Oertle et aI., 2003a) proteins are evolutionary conserved, and 
therefore their homo logs may exist in amphibians. 
In the salamander, an in vitro study using adult RGC, TN-R was shown to exhibit 
similar inhibitory substrate property as the mammals (Becker et aI., 1999). The 
expression study revealed the correlation of TN-R with myelination during 
metamorphosis and in the adult ON. However, in the case of ON crush, TN-R is 
shown to be down-regulated during axonal regeneration (Becker et aI., 1999). In 
anurans, there have been no studies done regarding TN-R up to date. However, 
Xenopus homologue of the TN-R receptor, contactin (also known as F3 in 
mammal, or F11 in chicken), has been identified (Nagata et aI., 1996). Similar to 
that in the nervous system of higher vertebrates contactin has also been shown 
to be essential for Xenopus nervous development (Fujita et aI., 2000). Thus, the 
presence of Xenopus contactin provides an indication for the possible existence 
of TN-R in the Xenopus laevis. 
Similarly in mammals, Nogo-A is an antigen for mAB IN-1 and also a myelin-
associated neurite inhibitor (Chen et aI., 2000; GrandPre et aI., 2000; Prinjha et 
aI., 2000). Previous studies in Xenopus have indicated the presence of IN-1 
antigen in Xenopus CNS. Furthermore, the neurite outgrowth inhibitory effects of 
Xenopus oligodendrocytes and myelin have been neutralized by IN-1 antibody 
(Lang et aI., 1995). Against this background, two nogolrtn4 genes were identified 
in Xenopus laevis recently (Klinger et aI., 2004), though the detail of expression 
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1.5 Aim and Objectives 
Many of the studies on neurite outgrowth inhibitors have been done in the 
mammalian eNS. However, detailed studies regarding the expression pattern 
and roles of TN-R and Nogo-A in lower vertebrates are primarily lacking. Thus, 
the analysis of these two proteins' expression and function in the eNS of lower 
vertebrates appears clearly warranted. Moreover, no data is presently available 
concerning putative receptors for either Nogo-A or TN-R in amphibians. This 
novel investigation on these two proteins will shed more insight into the 
mechanisms governing axonal regeneration, as well as into the evolution of glial 
cells and functions of these molecules in lower vertebrates. 
The aim of this study was to establish the expression pattern and the role of TN-
R, Nogo-A and their receptors in the eNS of Xenopus laevis frog and tadpole. 
Several objectives are outlined below: 
(i) To carry out a full expression study of TN-R, Nogo-A and their receptors in 
the Xenopus nervous system. 
(ii) To study the post-injury regulation of these molecules, i.e. the expression 
pattern of TN-R and Nogo-A in the lesioned nerve of Xenopus. 
(iii) To analyze the response of axonal growth cones and glia cells 
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1.6 Experimental Design 
1.6.1 Expression Studies 
In order to carry out a full expression study of TN-R, Nogo-A and their receptors, 
immunohistochemistry I immunocytochemistry were employed in the Xenopus 
frog and tadpole. A panel of cross-species reactive poly- and monoclonal 
antibodies against the protein of interest were used together with the specific 
cell-type markers as the double immunostaining in the whole mount tissue or 
frozen and/or paraffin sections. In addition, to study a detailed cellular expression, 
the double immunostaining was also performed in the cell cultures. 
1.6.2 Post Lesion Studies 
In anurans, metamorphosis is the critical point for the axonal regeneration; 
therefore the post-lesion study was done in both larval and adult Xenopus. The 
optic nerves were crushed in the anesthetized animals. The injured animals were 
allowed for recovery and then sacrificed at different time intervals. 
Immunohistochemistry assays were performed in the injured tissues, using 
double immunolabeling on the whole mount tissue or cryosections. 
1.6.3 Functional Studies 
Is regenerative success in the CNS of amphibians linked to permissive substrate 
properties of the microenvironment? Or, are these mammalian neurite outgrowth 
inhibitors simply not inhibitory to the CNS axons of amphibian? To address these 
questions, the responses of the growth cones was monitored using the TN-R or 
























2.1.1 Housing and Breeding 
The adult Southern African clawed frogs (Xenopus laevis) were bought from the 
Zoology Department of the University of Cape Town, and kept in large concrete 
tanks at the Anatomy Building of Human Biology Department in compliance with 
animal welfare legislation (Ethics approval number: Ref. No. 13/01). The frogs 
were fed on a diet of pieces of liver, mince and dry food pellets. For breeding 
purposes, both male and female frogs were kept in the lab tank and injected with 
the human chorionic gonadotrophin hormone (Profasi, South Africa or Pregnyl, 
Netherlands) to stimulate the spawning and fertilization of eggs. The tadpoles 
were reared on suspensions of yeast powder, and cared for in the lab tank with 
aeration. 
2.1.2 Dissection 
Both Xenopus frog and tadpole were terminally anesthetized with an overdose of 
0.1 % solution of MS222 (3-aminobenzoic acid ethylester; Sigma-Aldrich, Seelze, 
Germany) in tap water for tissue preparation. The tissue was dissected free with 
the aid of surgical instruments (listed below) in phosphate buffered saline (PBS) 
on ice under the dissection microscope (Olympus C011, Japan), and further 
processed using different protocols depending on the experiments carried out. 
Surgical Instruments Brand 
Dissection scissors Martin 
Iridectomy scissors Martin 
Surgical blades Swann-Morton 
Surgical forceps Martin 
Watchmaker's forceps Dumont 
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2.1.3 Optic Nerve Lesions 
The Xenopus tadpoles were selected at the stage of 50-58 according to the 
Normal Table of Xenopus /aevis (Nieuwkoop and Faber, 1956) prior to the 
operation. They were anesthetized in a 0.05% solution of MS222, and then 
placed in a glass Petri dish containing wet paper towel. Due to the transparency 
of the embryonic tissue (Fig. 2.1A), the pigmented optic nerves (ON) were easily 
found under the dissection microscope. At the midpoint of the ON between the 
eye and the cranium, the skin is opened to expose the nerve. The ON crush was 
made using the watchmaker's forceps (Fig. 2.1 B). The ON lesion was only 
performed unilaterally so that the animal is not completely blind and the other 
side of the ON was used as a control. The post-Iesioned animals were separated 
from the normal ones, and monitored in different tanks. The animals were 
sacrificed after different survival time intervals. Both injured and uninjured optic 
nerves were removed, and either embedded in tissue freezing medium (Jung, 
Germany) for cryosection or used as whole mount. 
For nerve lesions in frogs, all the procedures were similar to those above, except 
the ON was approached through a small opening made with razor blade in the 
roof on the mouth. The surrounding ocular muscle and blood vessels were gently 
pull away to expose the embedded ON. After nerve crushed, the frogs were kept 
in the lab tank and fed normally the next day. 
A B - -
Figure 2.1. Xenopus tadpole and optic nerve crush. (A) Xenopus tadpole. Most of 
the tissues are transparent, that makes the guts and pigmented melanocytes visible. 
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2.2 Immunoblot 
2.2.1 50S Gel Electrophoresis 
Freshly dissected tissues were transferred into a glass homogenizer with . . 
complete extraction buffer (freshly prepared from Aprotinin, PMSF and extraction 
buffer which contains 0.1 M Tris-HCI (pH 7.2), 1 % Nonidet P-40, 0.01% sodium 
dodecyl sulphate (SDS)) . After homogenizing the tissues thoroughly, the 
samples were centrifuged for 5 to 7 minutes at 4°C or 2 min at room temperature 
(RT). The resulting pellet was discarded, and the aliquots of supernatant could 
be stored at -80°C. 
The protein extracts were heated to 95°C for 2 min in reducing sample buffer 
containing 0.125M Tris-HCI (pH 6.8), 4% SDS, 10% 2-mercaptoethanol, 20% 
glycerol and 0.004% bromophenol blue. Aliquots of protein extracts and protein 
molecular weight marker were loaded onto a 7.5% or 10% SDS-polyacrylamide 
vertical gel (Bio-Rad, Italy) depending the molecular weight of the protein of 
interest. Gel electrophoresis started with 150V in the stacking gel, switched to 
180V in the resolving gel. The resulting gel could be checked by Coomassie-
Blue stain . 
2.2.2 VVestern Blot 
The proteins separated by SDS-gel were transferred onto nitrocellulose 
membranes (Hybond ECl, Amersham Bioscience) in a tank blot apparatus. For 
blocking , the membrane was incubated in blocking solution (3% (WN) non-fat 
dry milk, 0.3M NaCI and 0.05% (VN) Tween-20 in PBS) at RT for at least 1 hr 
with agitation. After which the membrane was incubated with the primary 
antibody in blocking solution overnight at 4°C or for at least 2 hours at RT with 
continuous agitation. Blots were rinsed twice in the above washing solution 
(0.3M NaCI and 0.05% (VN) Tween-20 in PBS) for 10 min each, and incubated 
with either anti-rabbit HRP-conjugated or anti-mouse HRP-conjugated secondary 
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solution at room temperature for 2 hours. Control blots were labeled without 
primary antibody, but secondary antibody only. Thereafter, blots were rinsed four 
times in washing solution for 10 minutes each, and developed using either the 
ECl Detection kit (Amersham Bioscience) or the Super Signal kit (Pierce, USA). 
The chemiluminescence signal was detected by Kodak medical film, which was 
developed according to standard procedures . . 
~'~ :. ., Primary Antibody Dilution Factor Source 
,~~ .. , .' 
Nogo (Bruna, polyclonal) 1 :10000 Gift of Dr. "M. Schwab, 
Zurich, Switzerland 
Nogo (702, polyclonal) 1 :10000 Produced by Dr. D. lang 
Nogo receptor (commercial, 1 :5000 Alpha Diagnostic 
polyclonal) International, USA 
Nogo receptor (antisera raised in 1 :5000 Own production 
rabbit) and pre-immune control 
sera 
T enascin-R (polyclonal) 1 :5000 Gift of Dr. P. Pesheva, 
Bonn, Germany 
Janusin (polyclonal) 1 :5000 Gift of Dr. P. Pesheva, 
Bonn, Germany 
Table 2.2. List of primary antibodies employed in the western blot. 
2.3 Antibodies and Immunohistochemistry 
2.3.1 Tissue Preparation 
For cryosections, the tissue was placed in aluminium molds embedded in the 
freezing medium. The specimen was allowed to equilibrate with the freezing 
medium for few minutes at RT or 1 hr at 4C, then snap-frozen in liquid nitrogen . 
Twelve to twenty-micrometer fresh-frozen sections were cut directly onto APTES 
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Germany). The sections were air dried, then fixed for 5 min in methanol at -20°C 
and 5 min in 4% paraformaldehyde (PFA; Merk, Germany) in PBS. The sections 
were washed three times for 5 min in PBS, and there after incubated in blocking 
solution containing 1 % bovine serum albumin (BSA; Roche Diagnostics, 
Germany) in PBS for 1 hour at room temperature. Subsequently, the treated 
sections were immunostained as described below. 
For whole mounts, the fresh tissue was fixed for 15 min in 4% PFA, then 15 min 
in methanol at -20°C. The whole mounts were washed three times for 5 min in 
PBS, and then incubated in the above blocking solution with extra 1 % dimethyl 
sulphoxide (DMSO) overnight at 4°C. After that, immunostaining was carried out 
according to the procedure below. 
2.3.2 Immunostaining and Imaging 
For immunohistochemical analysis on either the sections or whole mounts, the 
tissues were incubated with primary antibodies in blocking solution overnight at 
4°C (two nights for whole mounts). The tissues were then rinsed twice in PBS 
and incubated with the appropriate secondary antibodies for 2 hours at RT 
(overnight at 4°C for whole mounts). The antibodies are listed in Table 2.3. 
For membrane-bound proteins, such as 04 marker or GPI-anchored proteins, 
the culture live cells were incubated with the antibody in the medium at room 
temperature for 30-45 min, then rinsed with fresh medium and fixed in methanol 
at -20°C for one minute only. The cells were washed and immunolabeled as 
described above. The live-staining protocol was established in the laboratory and 
no internalization of the antibodies under these labeling conditions was observed 
previously (Lang, pers. comm.). 
The specimens were washed four times with PBS, and then the nuclei were 
labeled with DAPI (4' ,6-diamidino-2-phenylindole; Sigma) at 1 :50 dilution for 
5min in the dark. The tissue was mounted with Mowiol (polyvinylalcohol; Hoechst, 
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the conventional fluorescence microscope (Zeiss Axiovert) or confocal imaging 
system (Leica, TCS-SP). All the photos were taken with automatic exposure time 
determined by the camera/computer, unless specified for comparison of 
intensities. The images were further processed for clarity using Adobe 
Photoshop Without changing the information content. 
Few of the thick specimens were analyzed using Axio Imaging System with 
ApoTome slider (Fig. 2.2) (Zeiss Germany). The ApoTome slider is bearing grid 
pattern and imaging is based on the fundamental principle of "gird projection" or 
"structured illumination" (Bauch and Schaffer, 2005). Therefore, the resulted 
ApoTome image is an optic section through the sample without the out-of-focus 




~ 1 j 
ApoTome slider 
. "raw" image 
Figure 2.2. Axio Imaging System. The system consists of the ApoTome slider with 
a transmission grid inserted into the fluorescence beam path of the microscope. 
Three "raw" images at different Z-position are acquired with grid projection and 
calculated using a mathematical algorithm to reconstruct an optical plane. (Adapted 
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~~~~ry_.~,n~~~~I~y . Dilution Factor Source- -. 
. . "" 
~ . . ... 
F3 (pAS, rabbit) 1 :2000 Gift of Dr. G. 
Gennarini, Sari, Italy 
glial fibrillary acidic protein (GFAP, 1 :500 Sigma, Germany 
mAS GA5, mouse) 
GFAP (pAS, rabbit) . 1 :2000 Sigma, Germany 
myelin basic protein (MSP) 1:100 Gift of Dr. C. Linington, 
hybridoma supernatant (mAS, rat) Munich, Germany 
neurofilament (NF, mAS SM131, 1: 1 000 Sternberger -Meyer 
mouse) Monoclonals, 
Lutherville, USA 
Nogo-A (702, pAS rabbit) 1 :2000 Produced by Dr. D. 
Lang 
Nogo receptor (commercial, pAS 1: 1 000 Alpha Diagnostic 
rabbit) International 
Nogo receptor (antisera raised in 1: 1000 Own production 
rabbit) and pre-immune control 
sera 
04 hybridoma supernatant (mAS undiluted Gift of Dr. J. Trotter, 
mouse) Mainz, Germany 
Peripheral myelin protein PO 1:500 Gift of Dr. J. Archelos 
(mAS mouse) 
Tenascin-R (pAS rabbit) 1 :1000 Gift of Dr. P. Pesheva, 
Sonn, Germany 
Janusin (pAS rabbit) 1 :1000 Gift of Dr. P. Pesheva, 
Sonn, Germany 
Tenascin-R (mAS mouse) 1:500 Gift of Dr. P. Pesheva, 
Bonn, Germany 
~~~~ .-··-·:~5eco·n(ia·rY Antibody Dilution Factor Source - , 
~~·~-.:"'f~·",,",::-- - .. _~ - • _ _ _ _ • 
goat anti-mouse conjugated to 
alexa-488 
1 :1000 Jackson Immuno 
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goat anti-rabbit conjugated to 1:1000 Jackson Immuno 
alexa-488 Research West Grove 
PA, USA 
goat anti-rat conjugated to alexa- 1:1000 Jackson Immuno 
488 Research West Grove 
. PA,USA 
donkey anti-mouse conjugated to 1: 1 000 Jackson Immuno 
Cy3 Research West Grove 
PA,USA 
donkey anti-rabbit conjugated to 1 :1000 Jackson Immuno 
Cy3 Research West Grove 
PA,USA 
donkey anti-rat conjugated to Cy3 1 :1000 Jackson Immuno 
Research West Grove 
PA,USA 
donkey anti-mouse conjugated to 1 :1000 Jackson Immuno 
cy5 Research West Grove 
PA,USA 
Table 2.3. List of primary and secondary antibodies employed in the immunostaining . 
2.3.3 Diaminobezidine (DAB) Staining 
The activity of endogenous peroxidase of the tissue was quenched by 30 min 
incubation with 0.3% hydrogen peroxide in methanol at RT. The sections were 
then washed three times 5 min in TBS, and then incubated with the blocking 
solution containing 0.5% BSA in TBS for 30 min at RT. 
After blocking, the sections were incubated with primary antibody at 4°C 
overnight. Followed by four 10 min washes with TBST (1% Tween-20 in TBS), 
the sections were incubated with biotinylated secondary antibody for 1 hr at RT, 
then washed four times for 10 min with TBS. While washing, Avidin-Biotin-
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was pre-reacted for 30 min at RT. The complex solution was applied onto the 
sections for 30 min at RT, and then washed off by TBS. The sections were briefly 
rinsed with 0.05M Tris solution. The colour stain was achieved by 5 min colour 
reaction of DAB Peroxidase Substrate Kit (Vector Laboratories, USA). The 
sections were later washed for 15 min with tap water, and dehydrated with 
alcohols. Lastly, the sections were cleared in xylol and mounted with Entellen. 
2.3.4 Generation of Nogo-Receptor Antibody 
~ This part of the work was done together with and mostly by Dr. Edward 
Nyatia. 
~ All procedures were in compliance with protocols approved by the Animal 
Ethics Committee (Ethics approval number: REC REF: 03/009). 
The mouse and fish nogo-Alrtn-4 receptor protein sequences were aligned using 
the William Pearson's lalign program to locate the overlapping amino acids (aa). 
A short sequence of 8 aa (SLQYLRLN), that was conserved from mouse to fish 
was selected . A synthetic peptide with KLH (keyhole limpet hemocyanin) 
conjugation was made from Alpha Diagnostic International (see Appendix for 
data sheets), and introduced into two New Zealand White rabbits (animal 
identification : 452F675926 and 4530010111) to induce immuno-responce. The 
rabbits were kept in the Animal Unit at the University of Cape Town. 
Five inoculations were scheduled at time intervals to induce and boost immuno-
reaction. Before each administration of immunogen, serum was collected from 
both rabbits, including pre-immune serum, i.e. before the first inoculation . When 
collecting the blood, a portion of tail was swabbed with alcohol and a scalpel 
blade used to nick the site to expose the vein. The animals were anaesthetized 
using carbodioxide inhalation or sodium pentobarbitone injection. The desired 
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2.4 Cell Culture and Functional Analysis 
2.4.1 Glial Cell Culture 
Glial cell cultures were obtained from the brain and spinal cord of tadpoles or . . 
adult frogs. The only difference found between glial cells obtained from frogs or 
tadpoles was that more mature oligodendrocytes grew from the adult tissue. In 
addition, the neurite outgrowth was observed in the cultures of tadpole CNS 
explants. 
The brain and spinal cord were dissected in Leibovits medium (L 15, GibcoBRL) 
and the meninges were removed carefully. The tissue was chopped into small 
fragments with a Mcilwain tissue chopper (The Mickle Laboratory). The 
fragments were rinsed in L 15 containing 10% fetal calf serum (FCS, Highveld), 
then centrifuged briefly. The tissue was resuspended in glial culture medium, 
consisting of L 15/F12 (1: 1, Highveld) supplemented with 10% FCS, 0.4% methyl 
cellulose, 2mg/ml NaHC03 , 50lJg/ml gentamycin and 50lJg/ml amphotericin B. 
The suspension was placed on poly-D-Iysine coated glass covers lips (Marienfeld, 
Germany) in a sandwich culture (Fig. 2.3) as described by Lang et al (1995). The 
cultures were kept in a humidified chamber at 28°C in an incubator and 
maintained over several weeks. 
Figure 2.3. Schematic diagram of sandwich culture. Two stainless steel bars were 
placed between two glass coverslips. The bottom coverslip was coated with protein 
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2.4.2 Dorsal Root Ganglion Cell Culture 
Dorsal root ganglion (DRG) cell cultures were prepared from young adult frogs. 
The vertebral column was removed from the dorsal of the frog . The muscle and 
connective tissues were stripped to expose the dorsal root ganglia in between 
the vertebrates . The DRG was carefully dissected out in L 15 medium, freed of 
connective tissue as well as nerve roots and finally chopped into smaller 
fragments on the tissue chopper. The fragments were rinsed in L 15 containing 
10% fetal calf serum (FCS, Highveld), then centrifuged briefly. The tissue was 
resuspended in neuronal culture medium, and placed on poly-D-Iysine coated 
glass coverslips (Marienfeld, Germany) in a sandwich culture. The cultures were 
kept in a humidified chamber at 28°C in an incubator. 
2.4.3 Analysis of Substrate Property 
The coverslips were first coated with 0.1 % poly-lysine for 1 hour at room 
temperature . After a brief rinse with ddH20 and air dry, the coverslips were then 
coated with test proteins diluted in PBS to create a homogenous substrate. DRG 
microexplants were prepared from neonate rat or young adult frog, and cultured 
on the coated coverslips. The mammalian and amphibian cultures were kept in a 
humidified chamber at 3rC and 28°C incubator respectively. 
r. - :. 
Substrate Concentration Source 
If.-: .. . ., - ~y ..... ". I : 
Mouse laminin protein 100ug/ml Invitrogen 
Bovine serum albumin 100ug/ml Roche Diagnostics 
protein 
Nogo-P4 peptide 100ug/ml Alpha Diagnostic International 
purified mouse Tenascin-R 70ug/ml kind gift from Dr Pesheva, Bonn 
protein Germany 
purified fish Tenascin-R 70ug/ml kind gift from Dr Pesheva, Bonn 
protein Germany 
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2.4.4 Stripe Assay 
Stripe assays were prepared following established procedures (Bastmeyer et aI., 
1991). Striped substrates were created with the aid of a special silicone matrix 
containing parallel bars separated by channels in its central area (purchased 
from Dr S. Lang: Max-Planck-Institute, Tubingen Germany). The' matrix was 
sterilized by washing and autoclaving in ddH20, and then oven dried at 3rC 
overnight. The matrix was placed on a polylysine- or laminin-coated coverslip, 
and the channels were filled with the test protein or peptide by injection. The test 
protein or peptide was diluted in PBS to have the same concentration as stated 
in Table 2.4. The matrix with protein/peptide on the coverslip was incubated for 
an hour at RT. After the removal of the matrix, this procedure gave a patterned 
substrate of alternating lanes of polylysine and test protein/peptide. The Xenopus 
tadpoles were selected at the stage of 50-58 for the CNS primary culture. The 
tadpole CNS was dissected out according to Section 2.1.2 and cut into smaller 
pieces by using iridectomy scissors. Small fragments of neuronal explant were 
placed onto the coverslip perpendicular to the parallel lanes and cultured in a 
humidified chamber at 28°C incubator for 2-3 days (Fig. 2.4). 
A B 
Neuronal tissues Neuronal tissues 
Figure 2.4. Schematic diagram of stripe assay. A fragment of neuronal explant was 
placed perpendicular to the alternating lanes of polylysine and test protein/peptide 
(shaded lanes). Neurite outgrowth was either (A) elongating on the permissive lanes 
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1 2 3 4 M 
230kD 
Figure 3.1. Immunoblot analysis of TN-R expression in the rat and Xenopus. The 
pAB janusin detected double bands (two arrows) in : rat brain (lane 1), Xenopus frog 
brain (lane 2) and ON (lane 3), but not in Xenopus liver (lane 4) . The doublet has a 
molecular weight above 230kD. M, molecular weight marker; kO, kilodaltons. 
3.2 Expression of TN-R in Xenopus eNS 
During the mammalian CNS development and in the pathological conditions, the 
expression of TN-R has so far been associated with oligodendrocytes and 
subsets of neurons (Fuss et aI., 1993; Norenberg et aI., 1996; Pesheva et aI., 
1989: Rathjen et aI., 1991). From the immunoblotting results in this study 
(Section 3.1), TN-R immunoreactivity occurs in the CNS Xenopus frog and 
tadpole. To study the localization and developmental regulation of TN-R in the 
Xenopus, the nervous systems of the frog and tadpole were analyzed using 
immunohistochemistry. Double immunostaining technique was performed using 
the monoclonal or polyclonal antibodies against TN-R in combination with 
various cell type-specific markers to visualize the distribution and expression 
pattern of TN-R. 
3.2.1 In Spinal Cord 
To analyze whether TN-R immunoreactivity is localized in CNS myelin, 
myelinated tracts in the spinal cord (SC) of Xenopus frog were identified by 
myelin specific marker MBP. In the longitudinal section of Xenopus frog SC, 
staining of MBP antibody revealed labeling of fiber tracts in the white matter (Fig. 
3.2B). The staining of monoclonal antiserum against TN-R (mAB TN-R) revealed 
a nearly identical pattern to anti-MBP staining which indicates TN-R 
immunoreactivity in the myelinated area of the frog SC (Fig . 3.2A-C) . 
In different CNS regions of higher vertebrates, TN-R is also associated with 











r:h apter 3 Exp le s~.i o fl Ana lysis of T enasc lfl- R 
Bruckner et aI., 2003) . Thus, frog SC section was examined and stained with the 
polyclonal antibody against an IgSF glycoprotein F3, which is also known to be 
the receptor mediating the inhibitory effects of TN-R in mammals (Probstmeier et 
aI., 2000b; Pesheva et aI., 2006). The anti-F3 staining revealed the labeling of 
large neuronal somata in the gray matter of frog SC (Fig. 3.20). Although it was 
difficult to visualize the meshwork of perineuronal net, the labeling of mAB TN-R 
was found surrounding the F3-positive somata' (Fig . 3.20-E). This finding 
implicates the immunoreactivity of TN-R in the perineuronal nets of neurons. 
The different CNS regeneration capacity in anurans depends on the stage of 
metamorphosis, i.e. the tadpole SC can regenerate after injury (Beattie et aI., 
1990). To study the developmental regulation of TN-R in relation to myelin, the 
whole mount of Xenopus tadpole SC were double stained with TN-R (pAB 
janusin) and MBP antibodies and analyzed using the confocal microscopy (Fig. 
3.3). The high magnification image revealed the same labeling of MBP antibody 
in the myelinated tract of tadpole SC as in frog. The staining of pAB janusin 
showed a very similar pattern to that of anti-MBP. The immunoreactivity of TN-R 
was found in the MBP-positive fiber tract which indicates an association of TN-R 
with myelinated axons in the Xenopus tadpole SC, similar to that in the adult SC 
(Fig. 3.2A-C). 
On the other hand, in order to analyze the immunoreactivity of TN-R in relation 
with CNS glia, polyclonal GFAP (glial fibril acidic protein) antibody was counter-
stained with mAB TN-R in the cross section of tadpole SC (Fig. 3.4) . The staining 
of pAB GFAP displayed a fibril pattern, which extended from the spinal central 
canal into the white matter. The GFAP immunoreactivity was also found in the 
cell bodies (arrows in Fig. 3.4), which presumably were astrocytes with branched 
processes. The staining of mAB TN-R was predominantly found in the white 
matter labeled by anti-MBP (data not shown) but the distribution, however, was 
different from that of GFAP (Fig . 3.4A-0). Thus, the results suggest that TN-R 
immunoreactivity does not associate with astrocytes or astrocytic processes in 
the Xenopus tadpole SC. 
Figure 3.2. (next page) Immunohistochemical localization of TN-R in the Xenopus 
frog spinal cord. (A-C) The myelinated nerve fibers of white matter were labeled by 
both TN-R and MBP antibodies in the longitudinal section of frog SC. (O-F) The TN-
R immunoreactivity was also found in the perineuronal net of F3-positive neurons 
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Figure 3~3~ The confocal images of immunolocalization of MBP and TN-R in the 
Xenopus tadpole spinal cord . (Al The myelinated fibers in whole mount of SC were 
labeled by anti-MBP. (8) The nerve fibers were labeled by pAB janusin. (e) When 
two channels merged, the MBP and TN-R immunoreactivities were colocalized in the 
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Figure 3.4. Immunohistochemical localization of TN-R and GFAP in the Xenopus 
tadpole spinal cord . (A-D) The mAB TN-R was used together with polyclonal GFAP 
antibody in the cross-section of SC. The nuclei were labeled with OAPI. The 
multichannel image was shown in (0) . The GFAP-positive cells were indicated by 
arrows (B, and higher magnification in E), and the spinal central canal was indicated 
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It has been shown that TN-R is an intrinsic autocrine factor for oligodendrocyte 
differentiation in mammals (Pesheva et ai, 1997). Thus, the expression of TN-R 
was examined in the early developing SC of Xenopus tadpole. At this early stage 
of development, the spinal cord was not fully developed; the white matter and the 
gray matter were ill-defined, and consisted only of a few cells. The absence of 
MBP immunoreactivity in the section of developing tadpole SC indicates that 
myelination is yet to commence (data not shown). 
At this stage of development, the immunoreactivity of GFAP was found in the 
cross-section of tadpole SC, in which a single large cell with process extension 
was stained intensively with pAB GFAP and mAB TN-R (Fig. 3.5) . This finding of 
GFAP and TN-R co-expression at early developmental stage is contrary to the 
results obtained in tadpole SC at later developmental stage, where GFAP and 
TN-R immunoreactivities were not colocalized (Fig. 3.4A-D). However, it has 
been shovJn that the Xenopus oligodendrocytes express GFAP in culture (Lang 
et aI., 1995) and it is likely that TN-R expression is found in the GFAp· 
oligodendrocyte of developing tadpole SC before myelination. 
3.2.2 Expression of TN-R in the Optic Nerve and Retina 
Both Xenopus tadpole and frog are capable of regenerating optic nerve 
throughout life. To analyze the expression pattern of TN-R in the Xenopus visual 
system, whole mounts or sections of optic nerve (ON) and eye were stained with 
either mAB TN-R or pAB TN-R in combination with cell type-specific markers. 
The whole mounts of tadpole ON double stained with pAB janusin and MBP 
antibodies was analyzed using the confocal microscopy (Fig. 3.6) . The MBP 
marker labeled the myelinated fiber tract in the tadpole ON. The 
immunoreactivity of TN-R w.as also found in the nerve fibers, co-localized w(th 
the labeling of MBP antibody. In addition, TN-R (Janusin) antibody stained in the 
presumptive oligodendrocyte (arrows in Fig . 3.6), which was not yet fully 
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Similar expression patterns of MBP and TN-R antibodies were also found in the 
adult frog ON. Staining of the longitudinal section of frog ON with MBP antibody 
revealed dense labeling of myelinated fiber tract, which were also labeled by 
pAB TN-R (Fig 3.7 A-C). In the consecutive section stained by mAB TN-R and 
GFAP antibody, the staining patterns of mAB TN-R and GFAP were however, 
different from each other (Fig 3.7D-F). The immunoreactivity of GFAP appeared 
to be in the glial processes, as well as in the glial somata (arrow in Fig. 3.7E), 
whereas TN-R immunoreactivity was not detectable in these presumable 
astrocytic structures. Thus, these findings demonstrate the association of TN-R 
with oligodendrocyte and myelin in the optic nerves of tadpole and frog. 
In the avian and mammalian eye, the immunoreactivity of TN-R has been found 
at the outer plexiform layer of the retina (Bartsch et aI., 1993; Pesheva et aI., 
1989; Rathjen et aI., 1991). Therefore, the distribution of TN-R in the Xenopus 
retina was analyzed . The retinal sections from Xenopus frog eyes were stained 
with various antibodies against TN-R, GFAP, and TN-R interaction partner CSPG 
(Fig . 3.8) . The staining of both mAB TN-R and pAB TN-R showed intensive TN-R 
immunoreactivity in the outer plexiform layer, which was not labeled by GFAP or 
CSPG antibody. The GFAP immunoreactivity was found predominately in the cell 
bodies of glia in the RGC layer, as well as glial processes which dispersed in 
retinal layers (Fig. 3.8B). The immunostaining of CSPG was mutually exclusive 
from that of TN-R immunoreactivity in the adjacent retinal layers (Fig. 3.8D-F). In 
the control experiment without antibodies, fluorescent signals were detected in 
the photoreceptor layer due to autofluorescence (data not shown). This rules out 
any non-specific immunoreactivity of CSPG in the photoreceptor layer. The 
CSPG immunoreactivity was found only in the inner nuclear and RGC layers. 
These findings indicate the expression of TN-R is localized in the outer plexiform 
layer of frog retina but not associated with GFAP-positive glial structures, 
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Figure 3.7. Immunohistochemical localization of TN-R in the longitudinal section of 
Xenopus frog optic nerve. (A-C) The pAS TN-R and MSP antibody stained the 
myelinated nerve fibers of frog ON. (O-F) The mAS TN-R was counter-stained with 
GFAP antibody, which labeled astrocytic fibers and cell bodies (indicated by arrow). 
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3.2.3 Post-lesion Expression of TN-R 
As previously shown, the obtained immunohistochemistry results from the intact 
Xenopus ON (Section 3.2.2) indicate the expression of TN-R, a mammalian 
neurite outgrowth inhibitor, in the region of high regenerative plasticity. The 
regulation of TN-R expression after ON lesion has been studied in adult rat, fish 
and salamander (Becker C.G. et al., 1999, 2004; Becker T. et aI., 2000). To 
compare the post-injury regulation of TN-R in the Xenopus with that in other 
animals, the expression of TN-R was investigated following ON crush in Xenopus 
frog. The ON crush was performed unilaterally in the anaesthetized frog, thereby 
setting the unlesioned nerve as control. 
Two weeks (Fig. 3.9A) and three weeks after lesion (Fig. 3.9B), the whole 
mounts of injured ON were double stained with pAB TN-R and MBP marker. The 
unlesioned nerves were also processed with the same procedure (Fig. 3.9C). No 
difference was observed in the two weeks and three weeks control nerves (data 
not shown) . Apart from the injury site, the distribution of TN-R immunoreactivity 
in the lesioned ON appeared to be similar to that in unlesioned nerve at all post-
lesion time intervals studied. However, looking at the injured site under higher 
magnification, the intensity of TN-R immunoreactivity appeared to be slightly 
higher at the distal end than that at the proximal end (c in Fig. 3.9A-B). 
By examining the immunolabeling of MBP two weeks post-lesion nerve, the 
staining pattern at the proximal end differed from that at the distal end (Fig. 3.9A) . 
Unlike the intact nerve, the staining of MBP at the distal end dramatically 
changed from a fibril to irregular and granular pattern. The intensity of MBP 
immunoreactivity at the distal end was also higher than that of the proximal end . 
When comparing the distribution of MBP immunoreactivity between two weeks 
and three weeks (b & d in Fig. 3.9A-B), the granular staining pattern became less 
evident. In addition, the MBP staining was still slightly higher at the distal end 
three weeks post-lesion. 
Although the morphology of MBP-positive structures changed at different post-
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evident in the corresponding changes of MBP immunoreactivity. These 'findings 
show that in the course of frog ON degeneration/regeneration, changes take 
place in the myelin distribution concerning both morphology and expression of 
the myelin marker. In contrast, the distribution of TN-R persists in the frog ON 
after nerve crush. 
3.2.4 Expression of TN-R in Oligodendrocyte Culture 
Immunohistochemical characterization of TN-R in the CNS of Xenopus frog and 
tadpole indicate that the expression of TN-R is associated with oligodendrocyte 
and myelin (Section 3.2.2). This was further characterized by double staining 
with early oligodendrocyte marker 04 and TN-R antibody in the glial culture, 
which was prepared from frog SC. The cells which migrated from the fragments 
of spinal cord gave rise to heterogeneous cell populations with distinct 
morphology, such as the shapes of elongated bipolar, irregular polygonal and 
highly branched (Fig. 3.10A-B). Occasionally, there were enormously large cells 
i.e. up to 100IJm with extremely long processes extending to unaccountable 
distance (arrow in Fig. 3.10B). Amongst the different cell populations, the 
immunoreactivity of 04 was found specifically on the membrane of highly 
branched cells (Fig. 3.100), which was also labeled by pAB TN-R (Fig. 3.10C). 
Thus, the immunoreactivity of TN-R was associated with 04+ oligodendrocyte in 






























Figure 3.9. Post-lesion expression of TN-R in the whole mounts of frog optic nerve . 
(A) Two weeks post-jury: (a-b) Both TN-R and MBP immunoreactivities were found 
in the injured ON and weakly at the injury site (*). The arrowheads indicate the non-
specific signal from a cluster of dust and crystal. (c-d) Higher magnification images 
at the injured site (*). (B) Three weeks post-injury: (a-b) Both TN-R and MBP 
immunoreactivities were found in the injured frog ON at the proximal and distal end, 
but not at the injury site (indicated by *) . (c-d) Higher magnification at the injured site 
(*) . (C) Control : In the unlesioned control ON, TN-R and MBP antibodies labeled the 
myelinated nerve fibers. The nuclei were stained by DAPI. In all specimens the 
pigmented melanocytes were found and indicated by arrows. Scale bars in panels (A) 
and (B): b, 200~m; d, 100~m . Scale bar in panel (C): c , 100~m. 
Figure 3.10. Immunohistochemical localization of TN-R in the Xenopus glial culture. 
(A-B) Phase contrast images of the glial culture. The different cells migrated from 
the fragments of frog SC (indicated by *), including elongated bipolar cells 
(arrowhead) and large branched cells (arrow) . (C-D) Both pAB TN-R and 04 marker 
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3.3 Expression of TN-R in PNS 
The distribution of TN-R was initially thought to be CNS-specific in mammals. 
Recent findings have also shown the TN-R expression by Schwann cells in the 
developing mammalian PNS, suggesting TN-R may play a similar role in 
myelination as in CNS (Probstmeier et aI., 2001). To analyze whether TN-R 
immunoreactivity is present in Xenopus PNS as in mammals, the section of 
Xenopus frog DRG with peripheral nerve was stained with pAB TN-R (Fig. 3.11). 
Weak TN-R immunoreactivity was found in the somata of the ganglia. Around 
each individual neuron, intensive TN-R immunoreactivity was found in the 
satellite cells, which were special type of Schwann cell (arrows in Fig. 3.11 E). In 
order to judge whether TN-R immunoreactivity is also localized in PNS myelin, 
sections were counter-stained PNS myelin marker PO (Fig. 3.11 F-H). The 
myelinated peripheral nerve fibers exiting the frog DRG were labeled by PO, 
colocalizing with TN-R immunoreactivity. On the other hand, the connective 
tissues found in the peripheral nerve section, possibly perineurium or epineurium, 
were not stained by either PO or TN-R antibodies (* in Fig . 3.11 H). This verified 
the specificities of these two antibodies. These findings show that TN-R is also 












Chapter 3 Expression Analysis of Tenascin-R 
Figure 3.11. Immunohistochemical localization of TN-R in the section Xenopus frog 
DRG. (A-B) The section of frog DRG and peripheral nerve fibers were labeled by 
pAS TN-R. Compare with phase contrast image. (C-E) In the higher magnification 
image of DRG, the immunoreactivity of TN-R was shown in the satellite cells 
(arrows), together with DAPI stain . (F-H) TN-R and PO labeling were colocalized in 
the peripheral nerve fibers, but not in the connective tissues (*).The blue nuclear 
stain was included in multichannel images. DRG, dorsal root ganglion; PN, 
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4.1 Identification of Nogo-A in Xenopus 
Nogo-A is generally accepted as a mammalian neurite outgrowth inhibitor. The 
expression of Nogo-A have been studied extensively in higher vertebrates (Chen 
et aI. , 2000; Huber et aI., 2002; O'Neill et aI., 2004). To compare the distribution 
of Nogo-A in Xenopus with others, the specificity of the mammalian Nogo 
antiserum was first tested in the rat and frog material. The Nogo (Bruna) 
antiserum was generated against a 45kD recombinant rat Nogo-A fragment that 
recognized all mammalian forms of Nogo. Nogo (Bruna) antiserum has been 
shown to recognize a protein of about 220kD in bovine myelin and spinal cord 
extract in immunoblots (Chen et aI., 2000) . In the present study, anti-Nogo 
(Bruna) detected a band in the rat brain with molecular weight close to the 
literature results (Fig . 4.1A) . However, no Nogo immunoreactivity was observed 
in Xenopus tissues with this mammalian specific antiserum (data not shown). 
In order to recognize the Xenopus form of Nogo-A, the Nogo-A (702) antiserum 
was used instead of Nogo (Bruna) antiserum thereafter. The Nogo-A (702) was 
generated against a conserved region of Nogo-A peptide sequence in Xenopus 
and shown to be specific in Xenopus by previous western blots (Klinger et aI., 
2004). In the current study, immunoblotting revealed that Nogo-A (702) 
antiserum recognized a protein just below 230kD in Xenopus frog ON (Fig. 4.1 B, 
lane 1), brain (Fig . 4.1B, lane 2) and SC (Fig . 4.1B, lane 3) . In the same blot, a 
band with low molecular weight was also present in the frog ON and SC and was 
shown later to be non-specific. In addition, Nogo-A (702) also detected a band in 
the Xenopus tadpole CNS (data not shown), similar to that in frog CNS. 
The control experiments were performed by omitting primary antibodies, the 
results showed secondary antibody SAR-HRP (Santa Cruz Biotechnology) did 
not show any non-specific binding iri the brains of frog and rat (Fig. 4.1 C, lane 1 . 
and lane 2 respectively) . It was however cross-reactive with the frog ON (Fig. 
4.1C, lane 3) and SC (Fig. 4.1 C, lane 4) shown by the presence of 
immunoreactive band with low molecular weight. Thus, Nogo-A (702) antiserum 
specifically recognized Nogo-A protein in the Xenopus frog and tadpole with 
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Figure 4.1. Immunoblot analysis of Nogo-A expression in the rat and Xenopus CNS. 
(A) pAB Nogo (Bruna) detected a band slightly below 230kD in rat brain. (8) pAB 
Nogo-A (702) detected bands with molecular weight below 230kD in Xenopus frog 
CNS; ON (lane 1), brain (lane 2), and SC (lane 3). The results also showed a band 
present with a low molecular weight both in the ON and SC. (C) Experiments 
performed without primary antibodies: frog brain (lane 1), ra't brain (lane 2), frog ON 
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4.2 Expression of Nogo-A in Nervous System 
Nogo-A is shown to be associated with mammalian CNS myelin and 
oligodendrocytes (Huber et aI., 2002; Hunt et aI. , 2003; Taketomi et aI., 2002) . It 
is also believed to contribute to the failure of mammalian CNS axonal 
regeneration . However, as previously described in Section 4.1, the 
immunoblotting results strongly indicate the immunoreactivity of Nogo-A in 
Xenopus . To further analyze the expression pattern of Nogo-A protein in the 
Xenopus frog and tadpole, immunohistochemistry was performed using the same 
polyclonal Nogo-A (702) antiserum as tested in the immunoblots . 
4.2.1 Distribution of Nogo-A in Brain and Spinal Cord 
To establish an overview of Nogo-A expression in the Xenopus, staining of 
Nogo-A (702) antiserum in conjunction with DAB detection method was 
performed in the longitudinal section of frog SC. The irnmunoreactivity of Nogo-A 
was found in both white matter (VV in Fig . 4 .2) and gray matter (G in Fig. 4.2). In 
the white matter, intensive labeling of Nogo-A (702) antiserum was found in 
different diameters of axon fibers and scattered cell bodies. In the gray matter, 
the immunoreactivity of Nogo-A was detected strongly in the neuronal somata, 
judging from the morphology and localization of the frog SC. 
To clearly outline the white matter, the myelin marker MBP was used together 
with Nogo-A (702) antiserum in the cross-section of the frog SC (Fig . 4.3). The 
staining of MBP revealed dense labeling of myelinated fiber tracts in the white 
matter, while Nogo-A (702) antiserum labeled in both gray and white matter 
similar to that in the longitudinal section . In the ventral horn of the gray matter, 
strong Nogo-A expression was found in the somata of motoneurons. In the white 
matter, Nogo-A immunoreactivity showed intensive labeling of presumable 
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Figure 4.2. An overview of immunolocalization of Nogo-A in the Xenopus frog spinal 
cord. The DAB detection method has shown the immunoreactivity of Nogo-A in both 



















Figure 4.3. An overview of immunolocalization of I\logo-A and MBP in the spinal 
cord of Xenopus frog . (A) Labeling of Nogo-A (702) antiserum and (8) MBP in the 
cross-section of frog SC. (C) The merged image of two fluorescent channels. The 
space was a technical artifact indicated by (*). (0) Schematic diagram of cross-
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To further analyze the expression of Nogo-A in the Xenopus frog, Nogo-A (702) 
antiserum was used in parallel with various cell-type speci'fic markers (Fig. 4.4). 
In the longitudinal section of the frog SC, double staining of the myelin marker 
MBP and Nogo-A (702) revealed that the immunoreactivity of Nogo-A was found 
in the myelinated nerve fibers labeled by anti-MBP (Fig. 4.4A-C). The staining of 
the neurofilament NF antibody also revealed dense labeling of nerve fibers in the 
white matter of SC, but less intense in the gray matter (Fig. 4.4E). However, in 
the ventral region of SC gray matter, large neurons were found which were 
strongly labeled by Nogo-A (702) antiserum (arrow in Fig. 4.40). Among these 
fiber tracts, Nogo-A immunoreactivity showed up intensively in the scattered cells, 
which exhibit the morphology of oligodendrocyte with processes (arrowheads in 
Fig. 4.4). Although these presumable oligodendrocytes were MBP negative, no 
NF immunoreactivity was found either (Fig . 4.4G-I). The high power confocal 
images of whole-mount SC, containing 3-D information, revealed that the 
immunoreactivity of Nogo-A was found in the highly branched cell not labeled by 
anti-NF (Fig. 4.4M). This finding verified the glial expression of Nogo-A. In 
addition, the ependymal cells at the spinal central canal were also labeled by 
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Figure 4.4. Immunohistochemistry for Nogo-A and cell-type specific markers in adult 
Xenopus spinal cord. In the longitudinal section of frog SC, (A-C) the staining 
patterns of Nogo-A (702) antiserum and myelin marker MBP; (0-1) the staining 
patterns of Nogo-A (702) antiserum and the neurofilament marker NF. The 
immunoreactivity of Nogo-A was found in the oligodendrocytes (arrowheads) and the 
neuronal somata (arrow in D). (J-L) At the spinal central canal (indicated by * in J), 
Nogo-A expression was found in the ependymal cells, whose nuclei were labeled 
with DAPI. (M) Confocal images of the Nogo-A and NF expressions in the whole-
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In Xenopus, metamorphosis alters the regenerative ability (Beattie et ai, 1990), 
and therefore the expression pattern of Nogo-A was also studied in the crass-
section of tadpole SC (Fig. 4.6). These sections were obtained by cutting through 
the tail of the tadpole, in which the DAPI stain labeled the nuclei of the nervous 
tissues and the surrounding connective tissue. Nogo-A immunoreactivity was 
shown exclusively in the SC, but not in the surrounding connective tissues. Thus 
this rules out non-specific binding of Nogo-A (702) antiserum. High level of Nogo-
A immunoreactivity was found in the large neurons (arrow in Fig. 4.50) and 
smaller scattered cells, as well as the dorsal root ganglion (DRG) adjacent to the 
SC (Fig . 4.5G-I) . Staining of MBP revealed partial labeling of the tadpole SC, 
where presumptive white matter was found (Fig. 4.5B). MBP immunoreactivity 
was found mostly in the fiber tracts of ventral region and gradually decreased to 
the dorsal region. Despite the intense MBP labeling, the fiber tracts were weakly 
stained by NF (Fig. 4.5K). However, high NF expression was found in the cross-
section of the Mauthner axon, which was also labeled by Nogo-A (702) 
antiserum (Fig. 4.5M-O). Moreover, the oligodendrocytes with their processes 
around the Mauthner axon were strongly Nogo-A positive (arrowheads in Fig. 
4.5) . 
The above results described the immunostaining in the tadpole SC and indicate 
that the expression of Nogo-A correlates only partially with myelin. Thus, the 
expression of Nogo-A was further investigated in the non-myelinated regions of 
tadpole brain (Fig. 4.6), where MBP immunoreactivity was absent (data not 
shown). The staining of Nogo-A (702) was much weaker in the optiC tectum and 
fourth ventricle than in the rest of the brain (Fig. 4.6B-D). This difference could be 
due to the high density of nuclei in the regions labeled by DAPI. Staining of 
Nogo-A (702) and NF antibodies in the whole mount of tadpole brain revealed 
the colocalization and labeling of neuronal fibers and somata in the confocal 
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Figure 4.5. (previous page) Nogo-A immunoreactivity in the transverse sections of 
Xenopus tadpole spinal cord. All multichannel images include nuclear stain . (A-C) 
The Nogo-A (702) antiserum was counter-stained with anti-MBP. (D-F) High 
magnification images of boxed region in (A). Nogo-A (702) antiserum stained 
strongly in the motoneuron (arrow) and oligodendrocytes (arrowheads). (G-I) High 
magnification images of tadpole DRG (from * in A). Apart from the SC, the DRG was 
also strongly labeled by anti-Nogo-A. Anti-MBP labeled weakly the nerve fibers at 
the DRG. (J-L) The Nogo-A (702) antiserum was counter-stained with NF antibody. 
(M-O) High magnification image of boxed region in (J). The Mauthner axon was 
labeled by anti-I'JF. Scale bar: C, L, 200lJm; I, 501Jm; F, 0, 201Jm . 
A 
Cerebellum 
Hind MidI Forebrain 
~ \ --
F ou rth Ventricle -----,~:O:="" 
Figure 4.6. Immunolocalization of Nogo-A in the Xenopus tadpole brain. (A) 
Schematic diagram of lateral view of brain regions . (8-0) The longitudinal section of 
tadpole brain was labeled Nogo-A (702) antiserum. The expression of Nogo-A is 
found in the OT and hindbrain, where the nuclei were densely labeled by DAPI. 
There was non-specific fluorescent signal from a piece of thread (indicated by *). (E) 
Confocal image of Nogo-A and NF immunoreactivities in the whole mount of tadpole 
forebrain . The colocalization was found in the cell bodies (arrow) and fibers of the 
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The immunoreactivity of Nogo-A in the tadpole CNS has so far indicated the 
neuronal expression of Nogo-A in the developing nervous system. Therefore, it is 
of interest to investigate the expression of Nogo-A in the much earlier 
developmental stage where the myelination has not yet commenced. This can be 
shown by the absence of MBP immunoreactivity (data not shown). The 
transverse section of the early developing tadpole SC consisted of only few cells. 
The immunoreactivity of Nogo-A was found strongly among these cells 
demonstrating the morphology of neurons (Fig. 4.7), either presumptive neurons 
or neural progenitor cells. These findings suggest the Nogo-A expression is 
found even at the very early stage of nervous system development and 
associated with neurons before the myelination. 
Figure 4.7. Immunoreactivity of Nogo-A in the early developing spinal cord. (A) The 
cross-section of developing SC was labeled by Nogo-A (702) antiserum, and 
analyzed using ApoTome Imaging System. (8) The image of nuclear DAPI stain was 
captured using the conventional fluorescent microscope. Spinal central canal was 
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4.2.2 Nogo-A in Myelinated Tract of Optic Nerve 
Both Xenopus frogs and tadpoles are capable of regenerating the optic nerve 
(ON) after injury, hence the expression patterns of Nogo-A were examined in 
both frog and tadpole ONs. The immunostaining results described in the frog SC 
(Section 4.2.1) indicate the expression of Nogo-A in the myelinated fiber tracts. 
To study whether this association is also reflected in the frog ON, the myelinated 
fiber tracts were identified by myelin marker MBP ~s well as neurofilament NF 
antibody in the longitudinal sections of frog ON (Fig. 4.8). 
Both MBP and NF antibodies labeled densely in the myelinated fiber tract 
t~lroughout the section. The immunoreactivity of Nogo-A was colocalized with 
MBP and NF immunoreactivity in frog ON (Fig. 4.8A-F). In addition, the staining 
of Nogo-A (702) antiserum also revealed intensive labeling of cell bodies with 
foot processes representing oligodendrocytes (arrows in Fig . 4.8A-F). These 
presumable oligodendrocytes were not labeled by either MBP or NF antibodies. 
To further study these Nogo-A expressing cells in the frog ON, whole mounts 
were immunostained with Nogo-A (702) and anti-NF, and then analyzed using 
confocal microscopy (Fig. 4.8G). The immunoreactivity of Nogo-A was found in 
the cells scattered among the fibers and their processes were extended onto the 
nerve fibers (arrows in Fig. 4.8G). The NF antibody stained strongly in the nerve 
fibers, but not in these Nogo-A expressing cells presumed oligodendrocytes. 
Therefore, these findings have indicated that Nogo-A immunoreactivity is found 
in the oligodendrocytes and myelinated nerve fibers of frog ON. 
Similarly, the staining patterns of Nogo-A (702) and myelin marker MBP were 
found in the whole-mount of tadpole ON (Fig. 4.9). The staining of anti-MBP 
labeled the myelinated tracts of tadpole ON and colocalized with Nogo-A 
immunoreactivity. However, unlike the frog ON, the immunoreactivity of MBP 
was detected in the oligodendrocytes of the tadpole ON colocalizing with the 
Nogo-A (702) staining (arrow in Fig. 4.9). This result supports the identity of 
Nogo-A expressing cells in the ON as oligodendrocytes. Therefore, the 
expression of Nogo-A is associated with myelinated nerve fibers and 
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Figure 4.8. Immunohistochemistry for Nogo-A, MBP and NF in Xenopus frog optic 
nerve. (A-C) In the longitudinal section of frog ON, myelin marker MBP labeled the 
myelinated fibers, while Nogo-A (702) labeled the oligodendrocytes (arrow) and the 
fibers. (D-F) Both Nogo-A and NF immunoreactivities were found in the nerve fibers. 
The Nogo-A (702) also stained the oligodendrocyte (arrow). (G) In the confocal 
images of Nogo-A and NF in the whole mount of Xenopus frog ON, Nogo-A was 
expressed in the NF-negative cells with processes (arrows). (C and F) Multichannel 
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Figure 4.9. (previous page) Confocal images of Nogo-A and MBP in the Xenopus 
tadpole optic nerve. The immunoreactivity of Nogo-A was colocalized with MBP-
positive myelinated fibers in the whole mount of tadpole ON. Both MBP and Nogo-A 
(702) antibodies also labeled oligodendrocyte (arrow). The nerve sheath was labeled 
non-specifically (arrowheads) . 
4.2.3 Comparison of Nogo-A Expressions in Optic Nerve and 
Spinal Cord 
The results of the immunostaining experiments described in Section 4.2.1 and 
Section 4.2.2 indicate that Nogo-A is associated with myelin tracts and 
expressed in both SC and ON of frogs. However, the regenerative plasticity of 
the frog ON is different from the SC (Lang et ai., 1995). To verify whether the 
difference would be reflected in the intensity of the Nogo-A immunoreactivity, the 
data of immunostaining experiments carried out in frog SC was compared side 
by side with that of frog ON (Fig. 4.10). 
Though the immunoreactivity may depend on the amount of protein present and 
many vary from tissue to tissue, the camera attached on the fluorescent 
microscope will automatically adjust the exposure time to detect the fluorescent 
signals from the antibody. Since the absolute values for the intensity of 
immunoreactivities cannot be measured, the camera exposure time can be used 
as an indication of immuno-intensity, i.e. longer the exposure time, the weaker 
fluorescent signal, which indicates the weaker intensity of the immunoreactivity. 
In the immunostaining experiment, sections of frog SC and ON were 
immunolabeled with both Nogo-A (702) and MBP antibodies and their camera 
exposure time was recorded as a reference of immuno-intensity. In an attempt to 
have a direct comparison of the immunoreactivity, the time of exposure for the 
staining of Nogo-A (702) in the sections of frog SC and ON was set at the same 
time (Fig. 4. 1 OA&C). The immunoreactivity of Nogo-A was detected in the 
oligodendrocytes (arrows in Fig . 4.10) and myelinated tracts of both SC and ON 
and immuno-intensity at the same exposure time was stronger in the SC (Fig. 
4. 1 OA-D). Moreover, the recorded auto-exposure time for Nogo-A 
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4.10 E-F). Similarly, MBP immunoreactivity was also more intense in the frog SC. 
To sum up, these findings implicate that frog SC showed higher intensity of 
Nogo-A immunoreactivity than the ON. Furthermore, the comparison of MBP 
immunoreactivity intensities demonstrates the myelin is more compact and 
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Figure 4.10. Comparison of Nogo-A and MBP immunoreactivities in Xenopus frog 
optic nerve and spinal cord. (A-D) Both Nogo-A (702) antiserum and myelin marker 
MBP labeled the myelinated fiber tracts in the longitudinal sections of frog SC and 
ON. The camera exposure time for detecting Nogo-A and MBP immunoreactivities 
was set for 200ms and auto-exposure respectively. High level of Nogo-A 
immunoreactivity was found in the oligodendrocytes (arrows). (E) The auto-exposure 
time for Nogo-A and MBP immunoreactivity was compared in the graph. (F) Bar 
chart representing relative Nogo-A and MBP immunoreactivity intensity. ET, 
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4.2.4 Post-lesion expression of Nogo-A 
The results of mammalian post-lesion experiments have demonstrated that the 
application of the antibody against Nogo-A enhances the axonal regeneration in 
the mammalian eNS (Brbsamle et aI., 2000; Merkler et aI., 2001; Thallmair et aI., 
1998). In the present study, the immunostaining results indicate the expression 
of Nogo-A in Xenopus. In particularly, the adult and tadpole optic nerves are both 
capable of regeneration after injury (Gaze, 1970). Therefore, the success of 
axonal regeneration in frog and tadpole ON may be due to the downregulation of 
Nogo-A after injury. To examine whether the post-injury expression of Nogo-A 
was regulated and correlated with the Xenopus regenerative capacity, the 
distribution patterns of Nogo-A were analyzed in the lesioned nerves of both 
Xenopus tadpole and frog . 
The tadpoles received an ON crush unilaterally. After 5 days post-injury, the 
whole-mount of lesioned ON was double labeled with Nogo-A (702) and MBP 
antibodies (Fig. 4.11 A-B). The immunoreactivities of Nogo-A and MBP were 
found on the eye-side and brain-side of ON. However, the anti-MBP staining was 
hardly found around the injured site (indicated by *) where the Nogo-A (702) 
staining was weakly labeled. 
In order to achieve better details on the morphological changes, higher 
magnification images were taken with the aid of ApoTome system on the 
fluorescent microscope. This system eliminates out-of-focus information and 
enhances the sharpness of the image at each individual focal plane. When a 
stack of ApoTome images were taken at different depths of optical section and 
combined, the image of extended focus demonstrated clearer overviews of 
Nogo-A or MBP immunoreactivity in the specified regions of ON (Fig. 4.11 e). 
At the eye-side of the injured ON, the myelinated nerve fibers were stained by 
the anti-MBP (Fig. 4.11 e, panel-I). The fibers were also strongly labeled by 
Nogo-A (702) antiserum. However, these fibers, especially the MBP-positive 
nerve fibers disappeared before the lesion site (Fig. 4.11 e, panel-II). This 











Chapter 4 Expression Ana!ysis of Nogo-A and Nogo-Receptor 
contrast to the staining patterns at the proximal end, the staining of Nogo-A (702) 
and MBP antibodies demonstrated a much weaker and irregular labeling of fibers 
around the injury site (Fig. 4.11 C, panel-III). Moreover, numbers of Nogo-A 
positive cells with processes were found around the lesion site. At the distal end, 
MBP immunoreactivity reappeared in the fibers (Fig. 4.11 C, panel-IV). The 
staining pattern of Nogo-A (702) antiserum persisted in the presumed 
oligodendrocytes (arrow in Fig. 4.11 C) and much less in the fibers. 
These findings indicate that there is demyelination of the lesioned nerve and an 
activation of Nogo-A expressing oligodendrocytes following tadpole ON crush. 
Therefore, this post-lesion distribution of Nogo-A immunoreactivity does not 
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Figure 4.11. (previous page) Five days post-injury expression of Nogo-A in the 
tadpole optic nerve. (A-B) both Nogo-A and MBP immunoreactivities were weak at 
the injured site (indicated by *). (C) High magnification images of Nogo-A expression 
from proximal to distal end (indicated as I-IV in A). The immunoreactivity of Nogo-A 
was found in the presumable oligodendrocytes (arrows). Scale bar: B, 200lJm; C, 
501Jm. 
The post-lesion situation in the frog ON differs considerably from that in the 
tadpole ON, as the adult tissues require a longer period to regenerate. The frogs 
were therefore allowed to recover a longer time interval after receiving an ON 
crush. To analyze the Nogo-A expression in nerve fibers and myelin, the 
longitudinal sections of 2 weeks post-lesion ON were double stained by Nogo-A 
(702) and anti-NF, or Nogo-A (702) and anti-MBP. Weak NF immunoreactivity 
was found in the injured nerve when analyzed using conventional microscope 
(data not shown). The intensities resulted from these two immunostaining 
experiments cannot be directly compared (Fig. 4.12A-B), since the enhanced 
nerve fiber images were analyzed using ApoTome Imaging System (Fig. 4.12A) . 
In the injured nerve section stained by neurofilament NF antibody (Fig. 4.12A), 
the intensity of the staining was less at the eye-side than the brain-side. The 
distribution of NF immunoreactivity was found weakly in the central core of the 
ON and predominantly in the nerve fibers at the periphery of the ON. In contrast, 
the immunoreactivity of Nogo-A was found evenly throughout the ON section, 
and partially colocalized with the labeling of anti-NF in the fibers (arrows in Fig. 
4.12A). 
Similarly, the staining of anti-MBP was weaker at the proximal end than the distal 
end (Fig. 4.12B). However, the distribution of MBP immunoreactivity was found 
predominantly in the central core of the ON. The staining of MBP in the lesioned 
nerve did not reveal dense fibrous pattern parallel to the orientation ofaxons as 
did the intact nerve. 
Although there was no significant difference in the observed intensity of the 
Nogo-A (702) staining at both sides of the injured ON, there was a change in the 
predominant distribution of Nogo-A immunoreactivity (Fig . 4.12C). Despite the 
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labeled by Nogo-A (702) throughout the nerve section. The population of Nogo-A 
expressing cells in the injured ON increased dramatically compared to that in the 
intact nerve. In terms of morphology, these cells possessing Nogo-A 
immunoreactivity were smaller and rounder than the Nogo-A-positive 
oligodendrocytes observed in the intact nerve. It is noteworthy that these cells 
were also highly branched with processes extending to myelinated fibers and 
exhibited MBP immunoreactivity (arrowheads in Fig. 4.12). Therefore, they are 
likely to be oligodendrocytes expressing both Nogo-A and MBP in the frog ON 
after two weeks of injury. 
In the longitudinal section of injured ON 3 weeks following nerve crush, the 
immunoreactivity of MBP was barely detected around the lesion site (shown by *), 
but found in the fibers at the distal end (Fig. 4.13A-F). Apart from the ON tissue, 
a piece of peripheral nerve was found adjacent to the ON (PN in Fig . 4.13). 
Intensive labeling of MBP antibody showed the dens ly myelinated axons in the 
peripheral nerve, where the immunoreactivity of Nogo-A was also found. This 
result indicates the expression of Nogo-A in the myelinated tracts of PNS. 
The similar distribution of NF immunoreactivity was observed in the injured ON, 
but more fibers were labeled at the distal end (Fig. 4.13G-L). The staining of 
Nogo-A antiserum labeled weakly at the lesioned site (indicated by *) and 
increased gradually towards the distal end, where it colocalized with the staining 
of MBP and NF antibodies. The immunoreactivity of Nogo-A was found in both 
nerve fibers and cell bodies with processes representing oligodendrocytes 
(arrows in Fig. 4.13) and colocalized with anti-MBP labeling. These MBP-positive 
oligodendrocytes extended their processes onto the nerve fibers, this indicates 
the remyelination of the axons by the Nogo-A expressing oligodendrocytes. 
Taken together, these observations demonstrate that Nogo-A expression is 
found in the regenerating and remyelinating processes of frog nerve fibers. 
Moreover, the ON lesion induces an activation of Nogo-A expressing 
oligodendrocytes. Therefore, this distribution of Nogo-A immunoreactivity does 
not demonstrate a downregulation of Nogo-A following frog ON crush to support 
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Figure 4.12. Nogo-A immunohistochemistry analysis of after 2 weeks post-lesion 
frog optic nerve. (A) An overview of Nogo-A and NF immunoreactivities in the 
longitudinal section of frog ON analyzed using ApoTome imaging system. The NF 
and Nogo-A expressions was colocalized in the nerve fibers (arrows). The lesioned 
site is indicated by (*). (8) An overview f Nogo-A and MBP immunoreactivities in 
the longitudinal section of frog ON analyzed using conventional fluorescent 
microscope. The lesioned site is indicated by (*). (C) The high magnification images 
at the eye-sided and brain-sided of the injured nerve (indicated by I and II in B). The 
immunoreactivities of Nogo-A and MBP were colocalized in the myelinated fibers 
and oligodendrocytes (arrowheads). The signal of nuclear stain breached through 
the green-alexa channel (indicated by arrows). The multichannel images were 
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Figure 4.13. Nogo-A immunohistochemistry analysis of after 3 weeks post-lesion 
frog optic nerve. (A-C) staining of Nogo-A and MBP in the longitudinal section of 
injured frog ON. The adjacent peripheral nerve (PN) was labeled densely by both 
antibodies. The lesioned site was indicated by (*). (D-F) High magnification images 
at the distal end showed the colocalization of Nogo-A and MBP immunoreactivities 
in the nerve fibers and oligodendrocytes (arrows). (G-I) staining of Nogo-A (702) and 
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The lesioned site was indicated by (*). (J-L) High magnification image at the distal 
end showed the colocalization of Nogo-A and NF immunoreactivities in the nerve 
fibers. Staining of Nogo-A antiserum also labeled the oligodendrocytes (arrow). All 
the multichannel images were combined with blue DAPI nuclear stain. PN, 
peripheral nerve. Scale bar: C, 200jJm; F, I, 20jJm. 
4.2.5 Expression Analysis of Nogo-A in Culture 
Several structural studies have predicted that the two hydrophobic regions of 
Nogo-A protein sequence, are the two putative transmembrane domains. 
Furthermore, Nogo-A protein has been shown to express on the surface of the 
Nogo-A transfected cells (Chen et aI., 2000; GrandPre et ai., 2000). These 
expression and functional studies suggest that Nogo-A is expressed on the 
surface of the oligodendrocyte, thereby acting as contact inhibition on the 
mammalian neurite outgrowth. Results of the immunohistochemical 
characterization of the Nogo-A in this study indicate that the expression of Nogo-
A is associated with oligodendrocyte in the CNS of both frog and tadpole. To 
further characterize the ectopic expression of Nogo-A in oligodendrocytes, 
immunohistochemical analysis was performed on the live primary cell cultures. 
The primary culture was prepared from tadpole CNS explants, which gave rise to 
heterogeneous cell populations with distinct morphology and antigens. Cells 
migrated out of the explants were observed after 1 day. The cell populations 
consisted mainly of irregular polygonal cells, elongated bipolar cells, highly 
branched cells and flat cells. Occasionally, neurite outgrowth extended from the 
explant. If the cells had been cultured for a long period, the population of large 
flat cells resembling fibroblasts became the predominant cell type, and the 
neurites fasciculate. 
To identify the surface expression of Nogo-A, both live and fixed cultures were 
subjected to immunostaining of Nogo-A (702) antiserum and compared to each 
other. In addition, in order to recognize the oligodendrocytes among the cell 
populations, immunostaining of the oligodendrocyte marker 04 was applied to 
the live culture. The immunoreactivity of 04 was found specifically on the 
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the results obtained from the live-staining of both Nogo-A (702) and 04 
antibodies did not reveal any immunolabeling of anti-Nogo-A on the membrane 
surface of the 04+ oligodendrocytes (data not shown). The immunoreactivity of 
Nogo-A was observed only in the oligodendrocytes from fixed culture after 
permeabilisation (Fig. 4. 14A-C). Therefore, the expression of Nogo-A in Xenopus 
glial culture is associated with 04+ oligodendrocyte, but not on the membrane 
surface of the oligodendrocytes. 
In addition, the Nogo-A antibody also labeled the neuronal cell body with neurite 
extension, which was not stained by 04 marker (Fig. 4.14D-F). When the culture 
was subjected to immunostaining of neurofilament NF antibody, the 
immunoreactivity of NF was found together with that of Nogo-A in the neurites 
(Fig. 4.14G-I). This finding demonstrates the neuronal expression of Nogo-A in 
Xenopus. 
4.2.6 Nogo-A in PNS 
Initially, Nogo-A was identified in the CNS myelin in mammals and thought to be 
CNS-specific (Caroni and Schwab, 1988; Schwab and Caroni, 1988). 
Nevertheless, the immunostaining results in the present study have indicated 
otherwise. The Nogo-A immunoreactivity was found in the peripheral nerve of 
Xenopus frog (Section 4.2.4) as well as the spinal ganglia of tadpole (Section 
4.2.1). Recent mammalian studies have demonstrated high expression of Nogo-
A in the PNS neurons and axons after peripheral nerve injury (Hunt et ai., 2003). 
This correlation between Nogo-A expression and regenerative potential suggests 
that Nogo-A may be beneficial to regeneration by function within the axoplasm 
(Hunt et aI., 2003). Therefore, Nogo-A may be present in the Xenopus PNS in a 
similar distribution to that in the mammalian PNS, thus correlates with high 
plasticity. 
To characterize the Nogo-A distribution in the neuron and axon of Xenopus PNS, 
immunostaining of Nogo-A was done together with antibodies against 
neurofilament NF and peripheral myelin protein PO in the longitudinal sections of 
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intensive labeling of DRG neurons as well as the peripheral nerve attached to the 
DRG (Fig. 4.15A-C). The peripheral nerve fibers were also stained by anti-NF 
(Fig. 4.15D-F) and PO (Fig. 4.15G-L), colocalized with the Nogo-A 
immunoreactivity, indicating the expression of Nogo-A in the myelinated axons. 
Moreover, the Nogo (702) antiserum appeared to stain a thin layer at the edge of 
PO-positive myelin, indicating the immunoreactivity of Nogo-A is in the outer layer 
of the myelin sheath (arrowheads in Fig. 4.15). These findings strongly suggest 
that the distribution of Nogo-A in the Xenopus PNS is associated with neuron, 
myelinated axon and the outer layer of the myelin sheath. 
Figure 4.14. Immunohistochemical localization of Nogo-A in the Xenopus CNS 
culture. (A-C) Two individual oligodendrocytes were labeled by Nogo-A (702) and 
04 marker. The fluorescent signal from Nogo-A staining was so strong to breach 
through to green-channel (indicated by arrowhead). (D-F) Immunoreactivity of Nogo-
A was found in the neuronal cell body with neurite extension (arrow), which was not 
labeled by 04. (G-I) The neurites were stained by Nogo-A and NF antibodies. The 
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Figure 4.15. Immunoreactivity of Nogo-A in the frog DRG and peripheral nerve 
sections. (A-C) Under lower magnification, Nogo-A (702) antiserum labeled the 
neuronal cell bodies in the DRG (the insert), as well as PI\J . (D-F) Under higher 
magnification, immunoreactivity of Nogo-A was found in the NF-positive axons. (G-I) 
The PO antibody labeled the myelinated nerve fibers. (J-L) The cross-sections of the 
myelinated axons were stained by anti-Nogo-A and PO. The immunoreactivity of 
Nogo-A is also found at the edge of the myelin sheath (arrowheads). ORG, dorsal 
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4.3 Generation of Nogo-Receptor Antiserum 
In vitro experiments with the mammalian protein suggest that Nogo-A exerts the 
inhibitory effect in the C-terminal 66-amino acid loop (Nogo-66) which lies within 
the two putative transmembrane domains (GrandPre et aI., 2000; Fournier et aI., . 
2001; Oertle et aI., 2003). The characterization of the Nogo-66 loop has led to 
the identification of the Nog066-receptor (NgR) from a mouse brain cDNA 
expression library (Fournier et aI. , 2001). With the availability of the sequence, 
NgR homologs and NgR-related genes in many animals have been identified 
(Barton et aI., 2003; Fournier et aI., 2001). There are antibodies raised against 
mammalian sequences of NgR, such as those in rat, mouse and human 
(Fournier et aI., 2001; Wang X. et aI., 2002) and those are commercially 
available. However, in an attempt to allow a comparative analysis of NgR 
expression and function in mammals and lower vertebrates, such as Xenopus, a 
new antibody was raised against a region of NgR the sequence which is 
conserved across different species. 
More recent studies have identified the sequence of a NgR homolog in fish 
(Klinger et aI., 2004b). As no NgR protein sequences are available for Xenopus, 
NgR sequences alignment and phylogenetic analysis were done across 
mammals and fish using the blast algorithms of bioinformatics (Table 4.1). A 
short sequence of 8 aa (SLQYLRLN) is thought to be conserved from mouse to 











Chapter 4 Expression Analysis of Nogo-A and Nogo-Receptor 
C) IISREC-Server] Date: T ue Feb 22 II: 18 :59 Europe/Zurich 2005 
LALIGN finds the best local aligrunents between two sequences version 2.0u66 
September 1998 Please cite: X. Huang and W. Miller (1991) Adv. Appl. Math. 12:373-
381 
Comparison of: 
(A) . /wwwtmp/lalign/ . 23300.1. seq mouse 
- 473 aa 
(8) . /wwwtmp/lalign/.23300. 2. seq fish 
- 479 aa 
using matrix file: 8L50, gap penalties: -14/-4 
45.9% identity in 464 aa overlap; score: 1286 E(10,OOO): 2.ge-107 
10 20 30 40 50 60 
mouse MKRASSGGSRLLAWVLWLQAWRVATPCPGACVCYNEPKVTTSCPQQGLQAVPTGIPASSQ . . .. .... .... . . . ... ............. .... . ... '" .. 
fish MKTLIVEGGRLLCLMFWLNLVPVINSCPAKCVCYSEPKATVACQQQGLFSIPTEIPVRSQ 
10 20 30 40 50 60 
70 80 90 100 110 120 
mouse RIFLHGNRISHVPAASFQSCRNLTILWLHSNALARIDAAAFTGLTLLEQLDLSDNAQLHV .. . .. .. . . ..... . · . . . . . . . .. . ...... ........... ......... .. . ............ . 
fish RIFLQSNKLTVVRSTSFSSVHNLTVLWMYSNNISHIEAGAFYGLERLEELDIGDNSNLRI 
70 80 90 100 110 120 
130 140 150 160 170 180 
mouse VDPTTFHGLGHLHTLHLDRCGLRELGPGLFRGLAALQYLYLQDNNLQALPDNTFRDLGNL 
fish ISPTAFRGLTKLHTLHLHRCGLSELPVGVFRGLFSLQYLYLQDNNLLALHEDTFLDLANL 
130 140 150 160 170 180 










· .... .. .. . . . . . . . . . . .. ... . .. . · . . . . . . . . . .... . .. ................ ... ..... ..... . ... . 
TYLFLHNNKIKVVTDHMLRGLVNLDRLLLHQNRIVHVQQQAFNDLSKLTTLFLFFNNLTM 
190 200 210 220 230 240 
250 260 270 280 290 300 
LPAEVLMPLRSLQYLRLN DNPWVCDCRARPLWAWLQKFRGSSSEVPCNLPQRLADRDLKR 
" . . . . . . . . . . .......... . ... . · .. . .. . . . . .. .. . ........... ............ . .. . 
LTGESMNPLV ~ YLPLNGNQWICDCRARPLWDWFKRFKGSSSDLECHLPASLNGKDLKR 
250 260 270 280 290 300 
310 320 330 340 
LAASDLEGCA-----VASGPFRP-IQTSQ---LTDEELLSLPKCCQPDAADKASVL----. . . .. . .. " . . ..... 
LKSDDLEGCVDSPSQVQTSIFNSKVHSGKFLSLDDPLVESIPRCCLSDN-DKSSIISSKS 
310 320 330 340 350 
350 360 370 380 390 
--EPGRPAS---AGNALKGRVPPGDTP-------PGNGSGPRHINDSPFGTLPSSAEPPL . .. . .. . . . . . . .. ... .. . . ......... .., . 
IPDPSSYNSRQITNNPLKEKENISKTKFREVERTKNETRNKQSLNDGPLGTMSNNLDQSL 
360 370 380 390 400 410 
400 410 420 430 
TALRP---GGSEPPGLPTTGPRRRPGCSRKNRTRSHCRLGQAGS 
fish DRIDPELLGNLEPSTAPT---KKKKKCSKKPKSDQNCLKGHGST 
420 430 440 450 460 
Table 4.1. Comparison of mouse and fish nogo-Alrtn4-A receptor peptide 
sequences. The sequences were aligned using the William Pearson's lalign program. 
The selected sequence of interest was highlighted in red. (Alignment result was 
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4.4 Analysis of Nogo-Receptor Expression 
The expression of NgR has so far been described in the axons and cell bodies of 
neurons (Fournier et aI. , 2001 ; Wang X. et aI., 2002). In an attempt to study the 
expression of NgR in Xenopus, the staining pattern of the NgR antiserum was 
analyzed in the 'Xenopus neuronal cultures. 
Primary cultures containing heterogeneous cell populations were prepared from 
the tadpole CNS explants. There was numerous neurite outgrowth and even 
fasciculation, which was ideal for immunohistochemical analysis of NgR in 
association with axons. The immunoreactivity of NgR antiserum was found to 
colocalize with that of neurofilament marker NF in the neurites (Fig. 4.16A-B). 
However, the NgR antiserum also labeled the NF-negative cells. To verify the 
immunoreactivity of NgR antiserum in the neurites, control experiments were 
performed with pre-immune serum. The immunostaining of pre-immune serum 
also labeled the NF-negative cells from the explant, but not the neurites stained 
by NF marker (Fig. 4.16C-D). Additional control experiments were performed 
without primary. antibodies to verify the specificity of the secondary fluorescent 
antibodies. No signals were detected when staining with secondary antibodies 
alone (data not shown). In summary, though the newly raised NgR antiserum 
labels non-neuronal tissues non-specifically, it stains the neurites 'from the 
tadpole CNS culture. 
Results of immunoblotting revealed that NgR antiserum detected numerous of 
bands in the molecular weights range of 180kD and 60kD (Fig. 4.17A). One of 
the protein bands in frog spinal cord and weakly in frog brain may be of interest 
with an estimated molecular weight of 90kD (arrow in Fig. 4.17 A). On the other 
hand , the pre-immune serum recognized numerous protein bands, but none of 
them bear similar molecular weights to the NgR protein (Fig. 4.17B). The control 
blot without pri~ary antibodies did not show any non-specific ~inding by the 
secondary antibody SAR-HRP (Jackson Immuno Research, data not shown). 
This NgR antiserum has not yet been immuno-purified, and the normal serum 
from the rabbit exhibits non-specific binding to components of Xenopus tissues, 
which at this stage makes the use of this antiserum as a tool for specific NgR-
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Figure 4.16. Immunoreactivities of NgR antiserum in the Xenopus tadpole CNS 
culture. (A-B) Staining patterns of new NgR antiserum and NF antibody. The NgR 
antiserum labeled the NF+ neurites (arrows) specifically and other tissues (*) non-
specifically. (C-D) Staining patterns of pre-immune serum and NF antibody. The NF 
antibody stained neurites specifically (arrow) and the nuclei non-specifically (*). 
Scale bar: B, 0, 50lJm. 
A M FB FS B M FB FS 
180kD 180kD 130kD 130kD 
100kD 100kD 
70kD 70kD 



































Chapter 5 In Vitro Functional Analysis 
5.1 In Vitro Analysis 
In in vitro experiments using the mammalian homologues, tenascin-R (TN-R) and 
Nogo-A have been shown to possess inhibitory effects on neurite outgrowth. The 
results of the immunostaining experiments described in the present study confirm 
the expression of TN-R and Nogo-A in Xenopus. Thus, functional analysis was 
carried out to investigate whether these proteins exhibit similar inhibitory 
properties in Xenopus as in mammals. 
5.1.1 Substrate Properties of TN-R 
It has been shown that TN-R protein extracted from mammals inhibits neurite 
extension when provided with neuronal culture substrates (Becker C.G. et aI., 
1999, 2004; Becker T. et aI., 2000). To test whether mammalian TN-R exhibits 
the same substrate property in Xenopus neuronal tissues, the purified mouse 
TN-R protein was applied as a homogenous substrate and compared to non-
inhibitory control substrates. The native mouse TN-R protein .was kindly provided 
by Dr Pesheva who has shown the axon growth inhibitory effects of the mouse 
TN-R protein on the mammalian neurons (Fig. 5.1A, adopted from Pesheva et aI., 
2006). 
In primary cultures of the Xenopus tadpole CNS, the substrate properties of 
mouse TN-R were compared to the favourable substrate laminin and the neutral 
substrate BSA. Substantial neurite outgrowth and cell migration were found after 
3 days of culture on BSA and particularly on laminin substrate (Fig. 5.1 B). On the 
laminin substrate, the neurites were long extended and substantial cell migration 
out of the explants occurred. Neurite extension was also observed on the mouse 
TN-R protein substrate, together with a heterogeneous population of cells 
migrated out of the explant (Fig. 5.1 C). Neurite outgrowth, however, was 
observed much later than on the neutral or favourable substrates. Moreover, 
these neurites appeared to project from the explant onto the cells which had 
migrated out of the explant prior to the neurites. In order to differentiate the 
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immunostaining with anti-neurofilament (NF) antibodies. Immunoreactivity of the 
NF marker was occasionally found in the neurites which extended directly from 
the explant to the mouse TN-R substrate (Fig. 5.2A). The majority of the anti-NF 
labelled neurites were found on top of a layer of cells that had migrated and 
flattened out from the explant (Fig. 5.2B). The neurite outgrowth from the tadpole 
eNS explant did not appear to be inhibited by the mouse TN-R protein substrate, 
though there was a higher occurrence of growing neurite on the cells than on the 
homogenous TN-R protein substrate, indicating that the cellular substrate was 
preferred over the TN-R by the axons. 
Experiments in vitro initially demonstrated that the axons have no preference for 
eNS myelin on a patterned substrate, consisting of alternating lanes of myelin 
and poly-Iysine/laminin, in the so-called stripe assay (Bastmeyer et aI., 1001). 
When mammalian neuronal cultures are provided with alternating stripes of TN-R 
and favourable substrates, the neurites choose to grow only on the favourable 
substrates and avoid the TN-R protein boundary (Xiao et aI., 1997). Thus, to 
study the cellular responses of Xenopus neurons to a choice of mammalian TN-
R and a known favourable substrate, the stripe assay was performed using 
mouse TN-R protein and laminin. The purified mouse TN-R protein was applied 
as a substrate in a stripe pattern onto a homogenous layer of laminin substrate, 
thereby creating alternative lanes of laminin and TN-R protein substrates. 
However, the fish TN-R homolog might not exhibit the same inhibitory effects as 
mammalian TN-R protein . Thus fish TN-R protein was compared with that of 
mouse TN-R protein in the stripe assay. As a control , combination of BSA protein 
stripes on laminin substrate was tested . 
Both mouse TN-R/laminin and fish TN-R/laminin stripe assays supported 
vigorous outgrowth of cells and neurites from the explants of Xenopus tadpole 
eNS (Fig. 5.3). Due to the heterogeneity of the cell populations from the primary 
culture, it was extremely difficult to quantify and compare the numbers. The 
comparison between the stripe assays of mouse TN-R/laminin and fish TN-
R/laminin could only be done by observation and estimation . The spreading of 
cells covered the entire coverslip within 2 days of cultivation. However, there 











Chapter 5 In Vitro Functional Analysis 
together with neurite outgrowth in a stripe pattern (arrowheads in Fig. 5.3). This 
phenomenon occurred more frequently on mouse TN-R/laminin patterned 
substrates (Fig. 5.3B) than on the fish TN-R/laminin substrate (Fig. 5.3A). In the 
control stripe assay, no substrate preference was observed. The cells/neurites 
grew freely on the BSAIlaminin patterned substrate (data not shown). 
In order to visualize the association of neurite outgrowth to the patterns of TN-R 
protein substrates, the cultures of stripe assays were subjected to 
immunostaining with pAB TN-R and anti-NF mAB. TN-R immunoreactivity was 
found to occur in stripe patterns in both fish (Fig. 5.4) and mouse TN-R (data not 
shown) stripe assays. This confirms the presence of the patterned substrate of 
TN-R protein as well as the integrity of the protein in the stripe assay. In addition, 
there were pAB TN-R labelled cells on the stripes of TN-R substrate (Fig. 5.4B). 
These cells appeared to extend their processes onto the stripes of laminin 
substrates indicated by the negative TN-R immunoreactivity (arrows in Fig. 5.4B). 
However, no conclusive results were derived from the anti-NF staining due the 
loss of cells/neurites during the processes of fixing and washing (data not 
shown) . These findings indicate that when the TN-R and laminin proteins were 
used as culture substrates for the eNS of Xenopus tadpole, the outgrowth of the 
cells and neurites in general did not show significant avoidance of the TN-R 
protein . However, the comparison of axon growth on TN-R proteins derived from 
mouse and fish indicated that the substrate properties of mouse TN-R may be 
less permissive than those of fish TN-R, that at least mouse TN-R is capable of 
channelling growth of amphibian axons and that the signalling mechanisms 
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mouse TN-R 
c 
Figure 5.1. TN-R action on the neurite outgrowth. (A) Axon growth pattern of mouse 
cerebellar neurons on homogeneous BSA or mouse TN-R protein substrata 
(adopted from Pesheva et aI., 2006). (8) Tadpole CNS culture after 3 days on 
homogenous substrate of either BSA or laminin protein. There were outgrowth of 
neurites (arrows) and cells from the explants (*). (C) Tadpole CNS culture after 3-4 
days with neurite outgrowth (arrow) on homogenous mouse TN-R protein substrate. 
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Figure 5.2. Immunohistochemical analysis of NF in tadpole eNS culture on 
homogenous mouse TN-R protein substrate. (A) Neurite outgrowth (arrows) on 
homogenous mouse TN-R protein substrate. (8) Neurite outgrowth (arrows) on the 
cells migrated from the explant growing on a homogenous mouse TN-R protein 
substrate. The NF antibody labelled all the nuclei non-specifically. Scale bar: A, 
50jJm; 8, 100jJm. 
A fish TN-R mouse TN-R 
Figure 5.3. Primary culture of tadpole eNS on pattern substrates of TN-R proteins. 
(A) Phase contrast image of culture on pattern substrates of fish TN-R protein and 
laminin. (8) Phase contrast image of culture on pattern substrates of mouse TN-R 
protein and laminin. Explants of tadpole eNS were indicated by (*). The 
cells/neurites from the explants formed a pattern (arrowheads) in line with the 
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Figure 5.4. (previous page) Immunohistochemical analysis in TN-R stripe assay. 
(A) Staining with pAS TN-R labelled the stripes substrate of fish TN-R protein. (8) 
TN-R-positive cells on the TN-R protein substrate with processes extended to the 
laminin substrate (arrows) . Scale bar: A, 100jJm; S, 50jJm. 
5.1.2 Substrate Properties of Nogo-'A 
Functional experiments have demonstrated that Nogo-A exerts the strongest 
inhibitory effect in a hydrophilic region of 66-aa between two putative 
transmembrane domains, so called, Nogo-66 (GrandPre et aI., 2000). Within the 
same study, the application of a 25-aa peptide from the rat Nogo-66 region 
(designated as Nogo-P4) was sufficient to induce growth cone collapse and 
inhibit neurite outgrowth from chick DRG neurons and NGF-differentiated PC12 
cells (GrandPre et aI., 2000). 
To determine whether Nogo-A substrate property is non-permissive in Xenopus 
neuronal culture as described in the neuronal cultures derived from higher 
vertebrates (GrandPre et aI., 2000), primary cultures of the Xenopus tadpole 
CNS was cultured on the substrate properties of Nogo-P4 and compared to the 
favourable substrate laminin (Fig. 5.5). Striking difference on the outgrowth of 
cells/neurites was observed in the primary cultures on the laminin and Nogo-P4 
substrates. The neurite outgrowth was extensive and cells migrated out of the 
explants were massive on the laminin substrate, but not on the Nogo-P4 
substrate. 
The stripe assay was also performed using Nogo-P4 peptide together with 
laminin as pattern substrate (Fig. 5.6). In the assay, the cells/neurites appeared 
to be exploring the surrounding environment and changing directions (insert in 
Fig. 5.6C). After 2 days of cultivation , the outgrowth of cells and neurites from the 
explants of Xenopus tadpole eNS had already been channelled and formed a 
pronounced pattern of stripes. In order to visualize and verify the Nogo-P4 
peptide substrate pattern, the cultures of stripe assays were subjected to 
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mammalian Nogo (Chen et aI., 2000). Although there were no cells/neurites left 
after processing, the staining pattern of Nogo (Bruna) antibody revealed lanes of 
Nogo immunoreactivity (Fig. 5.7) corresponding to the stripes pattern seen in 
culture. Therefore, the Nogo-P4 peptide was exerting a channelling effect on the 
cells and neurites "from the explants of Xenopus tadpole CNS, thereby producing 
a stripe pattern of cell migration and neurite extension in the stripe assay. This 
indicates that, as for TN-R, the mammalian Nogo-A protein is capable of eliciting 
a response in the trog cells, pointing to a conserved signalling mechanism. 
Figure 5.5. Nogo action on the neurite outgrowth. Phase contrast image of culture 
on homogenous substrates of Nogo P4 peptide and laminin. Explants of tadpole 
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Figure 5.S. Primary culture of tadpole CNS on pattern substrates of Nogo P4 
peptide. (A) Phase contrast image of culture on pattern substrates of Nogo P4 
peptide and laminin. (8-C) Enlarged images of regions as indicated in (A). The 
cells/neurites from the explants were forming a pattern (arrowheads) in line with the 
direction of the substrate pattern (arrows). Scale bar: A, 200lJm; B, C, 100lJm. 
Figure 5.7. Immunohistochemical analysis in Nogo stripe assay. Staining with Nogo 























DISCLISSlon and Conclusion 
6.1 Discussion 
Neurons in the injured mammalian central nervous system (eNS) are unable to 
perform functional regeneration of their axons. This has been attributed to the 
unfavourable substrate properties of the microenvironment of the injured neurons, 
and in particular to the presence of neurite outgrowth inhibitory molecules, such 
as Nogo-A and tenascin-R (TN-R). Most studies on neurite outgrowth inhibitors 
are focused on mammalian eNS. Since lower vertebrates have an outstanding 
capability of regenerating eNS axons, detailed studies on the putative neurite 
growth inhibitors TN-R and Nogo-A in these animals will lead to a better 
understanding of the role of these molecules in axon growth and regeneration . In 
the present study, expression patterns of TN-R and Nogo-A were analyzed in 
Xenopus frogs and tadpoles. Since down-regulation of neurite growth inhibitors 
is a possible mechanism of facilitating axon regeneration after injury, the post-
lesion regulation of TN-R and Nogo-A was also studied in the optic nerve of both 
larval and adult Xenopus. Furthermore, the substrate properties of these proteins 
were investigated in order to. gain insight into their functional role in lower 
vertebrates. 
6.1.1 Tenascin-R in Xenopus 
Similar expression patterns of TN-R in Xenopus and higher vertebrates 
Initially, TN-R was identified from the mouse brain with molecular weights of 160 
and 180kD. In the present study, the presence of TN-R in Xenopus eNS is 
biochemically verified. From the imrnunoblotting results (Section 3.1), both two 
polyclonal antibodies against TN-R recognized a protein with two isoforms 
bearing high molecular weights in the Xenopus eNS. Previous sequence 
analysis attempts have been 'made at identifying the TN-R gene in Xenopus' 
tropicalis, close related to Xenopus laevis. Unfortunately, only a partial sequence, 
encoding for fibronectin (FN) type III domain, was found in the genomic database 
(Tucker et aI., 2006) . On the other hand, recent phylogenetic studies have 
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frogs , have two major 160 and 180kD forms (Pesheva et al ., 2006). Although 
there are no sequence data available yet, the unexpected high molecular 
weights of TN-R protein bands in current study are likely the result of high 
number of charged residues that may alter its mobility in the gel electrophoresis. 
The specificity of the antibodies was confirmed in the results of two TN-R 
isoforms in both mammalian and Xenopus CNS together with the similar staining 
patterns of both polyclonal and monoclonal TN-R antibodies. Moreover, these 
antibodies were also shown to recognize the TN-R protein of various species, 
such as mammals, avian, reptiles,. amphibians and fish, in a phylogenetic 
analysis (Pesheva et aI., 2006). Therefore, the TN-R antibodies specifically 
recognize TN-R protein with two isoforms in Xenopus in the present study. 
The TN-R protein has been shown to be associated with the myelin and 
oligodendrocytes in the CNS of higher vertebrates (Kruse et aI., 1984, 1995; 
Pesheva et aI., 1989; Rathjen et aI., 1991). The present immunohistochemical 
studies in the sections and whole mount tissues revealed that the 
immunostaining of TN-R was localized in the myelinated fiber tract in both spinal 
cords (SCs) and optic nerves (ONs) of Xenopus tadpole and frog (Section 3.2.1 
and 3.2.2) . Moreover, the expression of TN-R in Xenopus was also found in the 
presumable oligodendrocyte that was further verified by the immunostaining of 
the oligodendrocyte marker in the cell culture (Section 3.2.4). Therefore, the 
association of the TN-R with CNS myelin and oligodendrocytes correlated with 
the reported results on higher vertebrates (Fuse et aI., 1993; Kruse et aI., 1984, 
1995; Pesheva et aI., 1989). However, the expression patterns of TN-R in 
Xenopus raise the question about the functional role of a putative neurite 
outgrowth inhibitor in an animal capable of CNS axon regeneration . 
The sequence of TN-R is phylogenetically highly conserved (Pesheva et la ., 
2006 ; Tucker et aI. , 2006), and the ·protein is found in many species, including 
mammals (Fuss et aI. , 1993; Pesheva et aI., 1989), avians (Rathjen et aI., 1991), 
fish (Becker et aI., 2003) and amphibians (Becker et aI., 1999). Moreover, the 
same TN-R antibodies used in the current and previous studies (Pesheva et aI., 
2006) recognize the TN-R protein, possibly by the same epitope, in all vertebrate 
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different species, it may imply for likely functions, other than neurite inhibitory 
effects, of TN-R across species. For· instance, based on the association of the 
TN-R expression patterns with CNS myelin and oligodendrocytes, TN-R may 
playa role in myelination and oligodendrocyte function in Xenopus, as has been 
suggested in mammals (Fuss et aI., 1993). 
TN-R expression persists in the optic nerve of Xenopus after lesion 
In vitro functional studies have demonstrated the inhibitory effects of TN-R on the 
neurite outgrowth in neuronal cultures (Becker C.G. et aI., 1999; Becker T. et aI., 
2000). The role of TN-R in poor axonal regeneration has also been suggested. 
from the results of animal studies on CNS injury. The expression of TN-R after 
CNS injury has been investigated in adult rat, zebrafish Danio rerio and the 
salamander Pleurodeles Walt! (Becker C.G. et aI., 1999,2004; Becker T. et aI. , 
2000). After ON transection, TN-R expression in rat is upregulated at the lesion 
site where TN-R is assumed to contribute to axon growth inhibition and glial scar 
formation (Becker et aI., 2000). In contrast to mammals, after ON crush in the 
salamander, TN-R expression was downregulated at the lesion site, which could 
possibly contribute to successful regeneration (Becker et aI., 1999). In the 
present study, the post-injury expression patterns of TN-R were investigated in 
the Xenopus ON. In contrast to the downregulation of TN-R in salamander, TN-R 
expression persisted at the lesion site following frog ON crush . Reduced TN-R 
protein expression was also observed in the zebrafish, but the mRNA expression 
was surprisingly increased (Becker et aI., 2004) . This may have resulted from the. 
post-lesion response of oligodendrocyte dedifferentiation and redifferentiation 
(Becker et aI., 2004) . The expression of TN-R protein appeared again in the 
nerve with progressing remyelination of regenerated axons (Becker et al ., 1999, 
2004). 
It was suggested in zebrafish that TN-R acted as a repellent guidance molecule 
by forming a boundary and channel for growing axons in TN-R free regions 
(Becker et al ., 2003, 2004) . However, the distribution of TN-R immunoreactivity 
in Xenopus crushed nerve did not demonstrate any downregulation of TN-R after 
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changes of oligodendrocytes were observed (Section 3.2.3). These 
oligodendrocytes may indicate a change into an immature phenotype that no 
longer expresses myelin marker proteins such as MBP. Previous post-lesion 
studies of Xenopus frog ON have shown the possibility of oligodendrocyte 
dedifferentiation into immature oligodendrocytes after lesion and redifferentiation 
during remyelination (Lang et aL, 1996), as has been demonstrated in goldfish 
(Ankerhold and Stuermer, 1999). 
Interestingly, an upregulation of TN-R after ON crush also occurs in other fish 
and reptile species that regenerate axons, such as goldfish, cichlid fish and lizard 
(Lang, pers. comm.). In fact, TN-R has been shown to act as an intrinsic 
autocrine factor for the differentiation and maturation of oligodendrocytes 
(Pesheva et aL, 1997). Thus, the persistent expression of TN-R after nerve crush 
may be the result of a post-lesion response of oligodendrocyte dedifferentiation 
and redifferentiation in the animals that successfully regenerate axons. Hence, 
the success of the axonal regeneration in Xenopus ON is unlikely to be due to 
the TN-R downregulation at the lesion site as suggested in either salamander or 
zebrafish ON (Becker et aL, 1999,2003,2004). 
TN-R as a glial marker 
During mammalian eNS development, TN-R protein and mRNA are abundant in 
the presumptive white matter within the pathways of oligodendrocyte precursor 
migration (Pesheva et al., 1989). Furthermore, TN-R promotes oligodendrocyte 
differentiation and maturation in an intrinsic autocrine manner (Pesheva et aL, 
1997). In mammalian eNS cultures, TN-R antibodies labeled 04+ and/or A2B5+ 
oligodendrocyte progenitors and type-2 astrocytes (0-2A cells), but not GFAP+ 
type-1 astrocytes (Jung et aI., 1993; Pesheva et aI., 1989, 1997). The in vitro 
immunostaining results from the present study showed that TN-R protein was 
found in 04+ oligodendrocytes in Xenopus glial cultures (Section 3.2.4). In 
Xenopus eNS sections, TN-R immunoreactivity was associated with presumptive 
oligodendrocytes (Fig 3.6), but not the GFAP+ astrocytes and astrocytic. 
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suggest that TN-R may be expressed by 0-2A linage cells, but not astrocytes in 
Xenopus eNS. 
On the other hand, TN-R may also be expressed by immature oligodendrocytes 
which are GFAP+ in mammals. However, in Xenopus glial culture, it has been 
shown that the undifferentiated oligodendrocytes were A2B5-, while the 
differentiated oligodendrocytes retained GFAP (Lang et aI., 1996). The results 
from the current immunolocalization of TN-R, there were occasionally GFAP+ 
cells labeled by TN-R antibodies, though the expression of TN-R did not appear 
to be associated with astrocytes. Since the oligodendrocytes could retain GFAP 
in Xenopus glial culture, these GFAP+ TN-R+ cells in the Xenopus eNS may very 
well be either immature or differentiated oligodendrocytes. Thus, even though 
these differential marker expressions of Xenopus oligodendrocytes in different 
differentiation stages may not be the same as in mammals, TN-R can be 
considered an established marker for Xenopus oligodendrocyte linage cells. This 
also implies that TN-R possibly plays a role in amphibian oligodendrocyte 
differentiation and myelination similar to that in mammals. 
Apart from the eNS glia and myelin tissues, TN-R expression was found in the 
Schwann cells of both mammalian (Probstmeier et aI., 2001) and Xenopus PNS 
(Section 3.3) . While the exp ession of mammalian TN-R has been found during 
PNS development and downregulated at later developmental stages 
(Probstmeier et aI., 2001), the immunoreactivity of TN-R in Xenopus was found 
to persist in the adult. In the same study, TN-R immunoreactivity was associated 
with Schwann cells in the degenerating nerve stump after adult sciatic nerve 
injury. A functional role of TN-R has thus been suggested in PNS myelination as 
well as PNS pattern formation in terms of axon pathfinding (Probstmeier et aI., 
2001). Although more functional analyses are required, it is possible that TN-R in 
Xenopus PNS is playing a similar ~ole as in the mammalian PNS. Moreover, 
Schwann cells are able to produce neurotrophic factors and neurite outgrowth 
promoting cell adhesion molecules, thereby creating a permissive environment in 
the PNS especially during regeneration (for review, see Goldberg and Barres, 
2000). Therefore, an association of Xenopus TN-R with Schwann cells suggests 
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overriding of the inhibitory effects of TN-R by the high levels of axon growth-
promoting components. 
TN-R and its interaction partner CSPG in Xenopus 
In the avian, mammalian and fish retina, TN-R has been found in the horizontal 
cells on the outer plexiform layer (Bartsch et aI., 1993; Becker et aI., 2003; 
Pesheva et aL , 1989; Rathjen et aL, 1991). In Xenopus retina, TN-R was also 
found on the outer plexiform layer. Thus, the interspecies comparison of TN-R 
neuronal expression is not very different between Xenopus and the other 
vertebrates . Interestingly, the immunoreactivity of CSPG was found in the inner 
nuclear layer adjacent to that of TN-R in the frog retina (Fig. 3.8). 
CSPGs are a heterogeneous group of molecules with distinct core proteins. 
During CNS development, the migrating celis and growing axons avoid CSPG-
expressing areas in ECM (Friedlander et aL, 1994). In a CSPG substrate border 
study, neurite growth of chick DRG explants did not grow over the border into the 
CSPG containing area (Niederost et at., 1999). Additionally, the presence of 
CSPGs in the injured mammalian CNS, mostly in the glial scar tissues, 
contributed to the axon growth-inhibitory environment (Asher et aL, 2002; 
Lemons et aL, 1999). Thus it might also contribute to the failure of CNS axonal 
regeneration . 
Biochemical studies have demonstrated that TN-R is capable of forming 
complexes with CSPGs by protein-protein interaction (Asperg et aI., 1997). 
Members of CSPG have been shovyn to interact and co-express with TN-R in 
oligodendrocytes, demonstrating inhibitory effects on neurite outgrowth in 
mammals (Asher et aL, 2002; Probstmeier et aL, 2000a, 2000b). Moreover, an 
upregula~ion of TN-R at the lesion site possibly promotes glial scar formation in 
association with CSPGs (Probstmeier et aL, 2000b). Given that both TN-R and 
CSPG have been shown to inhibit axon growth, the association of TN-R and 
CSPG could constitute a particular non-permissive substrate. Thus, it is of 
interest to find the expressions of both putative mammalian neurite outgrowth 











Chapter R DisCLL.slon and Co nc lusion 
regenerating optic nerve throughout life. Alternatively, the CSPGs could 
modulate the repulsive activity of TN-R by forming complex with TN-R, thus 
hindering the inhibitory domains and thereby neutralizing the effects. Although 
further functional analysis is required, the immunostaining results from the 
Xenopus retina sections may imply an association or interaction of TN-R and 
CSPG in Xenopus. 
Possible interactions of TN-R with F3/11 and other unidentified receptors 
Apart from the expression of TN-R by horizontal cells in the retina, the neuronal 
expression of TN-R in mammals has been shown to accumulate in perineuronal 
nets of interneurons and motoneurons in different parts of the CNS (Angelov et 
al., 1998; Bruckner et ai., 2003, 2006) . Perineuronal nets appear as mesh-like 
structures on the cell surface as a result of ECM molecular composition . The 
presence of TN-R, a neurite repulsive substrate, proposes that the perineuronal 
nets may serve as a barrier for the formation of new synaptic contacts . Although 
the functions of the perineuronal net are not fully understood, knowledge of the 
molecular components leads to the postulation of its functional roles, such as 
maintenance of synaptic plasticity (for review see Celio et ai., 1998). 
Similar expression was observed in that TN-R was found in perineuronal nets of 
F3-posivite neurons in the Xenopus frog SC. In mammals, F3/11 is expressed on 
the cell surface membrane and is implicated in both axonal growth and 
synaptogenesis (for review, see Falk et aI., 2002). The Xenopus F3/11 
homologue, contactin , was shown to be expressed in both adult and embryonic 
CNS of Xenopus and it is essential for Xenopus nervous development (Fujita et 
ai., 2000; Nagata et ai., 1996), similar to the nervous system of higher 
vertebrates. Although the repulsive property of TN-R for neurite outgrowth was 
shown to be mediated by this, neuron-specific glycoprotein F3/11, this neurite, 
outgrowth inhibition was also shown to be F3/11-independent by its interaction 
with an as yet unidentified receptor (Probstmeier et ai., 2000b). Furthermore, fish 
TN-R protein was shown to be more permissive than the mammalian TN-R 
protein and the neurite outgrowth inhibition was suggested to be partial 











Chapter G DisCLISSlon and Conclus ion 
This difference on the substrate properties between the mammalian and lower 
vertebrates TN-R proteins was also obseNed in the functional analysis of the 
present study (Section 5.1.1). Thus: it seems reasonable to assume a similar 
association of F3 with TN-R in the roles of synaptogenesis and axon pathfinding 
in Xenopus frog as in mammals. However, TN-R protein is more permissive in 
the lower vertebrates and less independent on the F3/11/contactin-mediated 
neurite inhibition. Therefore, Xenopus TN-R protein may interact with other 
unknown receptors and partially inhibit the neurite outgrowth in Xenopus frog. 
TN-R may perform functions other than inhibiting neurite outgrowth in 
Xenopus 
Based on the expression pattern in mammals, TN-R was implicated in cell 
interactions, which playa vital role in development of the neNOUS system. A 
number of in vitro functional studies were done to investigate the substrate 
properties of TN-R (Angelov et aL, 1998; Liao et aL, 2005; Pesheva et aL, 1989, 
1994, 1997; Probstmeier et aL, 2000a; Rathjen et aI., 1991). Sulfatide-mediated 
cell adhesion was demonstrated in the oligodendrocyte cultures (Pesheva et aL, 
1997). FN-mediated cell adhesion and neurite outgrowth could be interfered with 
by TN-R (Pesheva et aL, 1994; Probstmeier et aI., 2000a). On the other hand, 
the expression of the TN-R interaction partners FN and laminin is upregulated 
together with that of TN-R in the lizard after ON crush (Lang, pers. comm .) and 
thus these ECM proteins may act in concert as instructive signals for axon 
growth . TN-R expression also persists after ON crush in Xenopus. Although the 
post-lesion expression patterns of FN and laminin have not yet been examined in 
Xenopus, an increase intensity of laminin has been shown in the CNS of 
axotortlized Rana frog (Matesz et al:, 2005) . These effects suggest that TN-R 
possibly plays an important role in myelination, as well as having a role in an 
interaction between TN-R and its interaction partners that may imply a role of 
TN-R as a modulator in ECM interactions. TN-R substrate has also been shown 
to be anti-adhesive for activated microglia (Angelov et aL, 1998; Liao et aL, 2005) 
and neurons (Pesheva et aL, 1989). In a mixture of TN-R and adhesive 
substrates, neural cell attachment was not stimulated and furthermore neurite 
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interesting to investigate whether TN-R is also anti-adhesive for microglia in 
Xenopus, as activation and migration of macrophage-like. cells is 
considered crucial for successful axon regeneration (Angelov aI., 1998). 
investigate substrate properties, TN-R was used in neurite outgrowth 
Xenopus neuron and glia cultures. Using the. tadpole CNS primary . 
culture in assay it was difficult to yisualize the direct effect of TN-R upon the 
neurites among the heterogeneous population., LJ .... ,,, ........ on distribution 
anti-NF immunoreactivity, of the neurite outgrowth on the homogenous 
substrate· of mammalian TN-R avoided making direct contact with the protein 
substrate but onto cells-instead 5.1). The substrate property of 
mammalian TN-R has also· 
outgrowth of mammalian, fish 





suggests that the mammalian TN-R, as a 
sole substrate, may exhibit a high degree of inhibitory effects on the outgrowth of 
Xenopus neurc;>ns, 
Different form of substrate preparation, such as homogenous and patterned, 
rise to different types of in vitro cellular responses. stripe is ideal 
the studies on substrate choice and. guidance of extending aXOn. Thus, the in 
vitro effect of the TN-R protein on Xenopus neurite outgrowth was further 
analyzed by offering the neurons alternating parallel lanes of TN-R and control 
. substrate. Ideally, different of should be done compare neurite 
outgrowth on combination _ of inhibitory, or favourable and "neutral" protein . 
substrates. Yet, simply by comparing the in vitro of mammalian and 
TN-R, - neurite outgrowth the Xenopus neurons did not appear to be 
inhibited substantially by either mammalian and an even extent by -fish 
TN-Rsubstrates (Fig. 5.3). This could be attributed to presence of laminin, 
one of the TN-R interaction partners (Bruckner et aI., 2003; aI., 1989), 
as positive· substrate it may counteract the inhibitory effects of TN-R. could 
also possibly be attributed to a possibly different inhibitory action of TN-R from 
different organisms (Pesheva et ,2006), since most of the studies on neurite 
inhibition been done and described with mammalian TN-R (Becker C.G. 












such as the existence of different receptor(s) or conformatfon. of 
receptor-ligand binding sites in di'fferent interactive responses, be 
different from that of mammalian neurites. Alternatively, it can be argued that the 
TN-R substrates may not be non-permissive in Xenopus. 
6.1.2 Nogo-A in Xenopus 
Nogo-AlRTN4-A orth%g in Xenopus 
CNS myelin and oligodendrocytes of Xenopus spinal- cord (SC) are known to 
be nonpermissivefor neurite outgrowth, however, the inhibition for neurite growth 
neutralized by the monoclonal inhibitor-neutralizing antibody mAB IN-1 (Lang 
et ,1995). Furthermore, in mammalian spinal cord injury model, neutralization 
of non-permissive substrate property by mAB IN-1 lead to promote axonal 
regeneration as well as functional. motor recovery (Bregmari aL, 1995; 
Brosamle ,2000; Merkler et aI., 2001; Spillmann aI., 1998; Thallmairet 
1998). Since Nogo-A shown to be an antigen of IN-1 (Chen aI., 2000). it can 
be postulated thCit Nogo-A in contributes to hostile environment for CNS 
axon growth in Xenopus Together with the phylogenic analysis of reticulon .. 
family (Oertle aI., 2003a), the Nogo-AlRtn4-A ortholog in Xenopus frogs . 
was (Klinger aI., 2004a). In the same study, two independent rln4.1 
and rln4.2 were identified and the resulting three transcripts, rtn4-A, 
and were those in mammals. However, the molecular weight of 
Xenopus Nogo-A protein was shown to be slightly lower than· the mammalian 
Nogo-A (Klinger et aI., 2004a). , 
the present immunoblotting analysis, the ,same antiserum against Xenopus 
Nogo-A by Klingeret al. a protein band in Xenopus 
of a similar molecular weight the band in rat CNS recognized by mammalian 
specific Nogo-A antibody. The current immunoblottingresults are consistent with 
previously published results (Chen aI., 2000; Klinger et aI., 2004a). In addition, 
there 'were bands with low molecutar weight the Xenopus, however, 











Cha , Discussion 
,experiment. Thus, the specificity the Nogo-A ""nt'le!o. is confirmed in current 
'work and the Nogo-Aimmunolabelling in the Xenopus CNS can be considered 
specific. 
On the other hand, there remains some uncertainty of Nogo-A as an antigen of 
original mAB IN-1 which could suggest functions of Nogo-A other than 
inhibition. IN-1 antibody was against NI-250 which was initially 
identified from mammalian CNS myelin extract (Caroni and Schwab, 1988). In 
mammalian expression studies, staining patterns IN-1 antibody in the adult 
CNS were to those mammalian, Nogo-A antibodies (Chen at., 
2000). However, the lack of IN-1 immunoreactivity in the Xenopus ON (Lang et -
aI., 1995) is in contradiction to the results obtained in this study, which strongly 
demonstrated Nogo-A immunoreactivity in both tadpole and frog ON. This 
, controversy has raised the question on recognition of Nogo-A by IN-1, since no 
direct evidence has been presented so far the biochemical analysis of this 
aspect has turned out to be difficult. This is due to the of mAS IN-1, which 
belongs to the IgM, isotype family. Another challenge within full 
purification of the original IN-1 antigen, NI-35/250, thus no direct comparison 
between the NI-35/250 and Nogo-A could elucidated. Therefore, one could 
argue that the inhibitory activity concluded by many studies of 
regeneration using IN-1 neutralization was the result of IN-1 recognizing a 
different epitope of Nogo-A. This could also to clarification of a variety of 
unknown' functions of Nogo-A. 
Interestingly, the mammalian specific Nogo-A antibody did not recognize Nogo-A 
in the Xenopus CNS in present study. Thus. one could argue the degree of 
conservation of Nogo-A structure function in different species. On the other ' 
hand, the mammalian Nogo-A P4 peptide has demonstrated a high degree of 
repulsive effects on the outgrowth 9f Xenopus axons in the functional assays, 
indicating conservation the signalling pathways mediating the inhibitory action 
of Nogo-A. In high variability of Nogo/RTN4 sequence conservation has 
been observed in vertebrates (Dertle aI., 2003a). Furthermore, some inhibitory 
domains Nogo-A are only present with weak similarity in amphibians (Oertle 











6 and .Conclusion 
Nogo-A is not inhibitory to the XenopiJs neurite outgrowth. It is possible 
evolution of Nogo/RTN4 may to protein structural divergence which may 
result in functional divergence, 
issue. 
more thorough studies are needed on this 
Nogo-A is associated·with oligodendrocytes and myelin. . 
Nogo-A is strongly expressed in oligodendrocytes and myelinated tracts of the 
mammalian eNS (Chen 2000; Huber et , 2002). In Xenopus frog and 
tadpole CNS, the immunoreactivity of Nogo-A was found in the highly branched 
oligodendrocytes and myelinated nerve fibers of the SC and optic nerve (ON). In 
addition, the expression of Nogo-A' was found in the myelinating 
oligodendrocytes of tadpole ON as' indicated. by the high. level of 
myelin protein. 
CNS is """'''''-' ..... 
findings imply that the expression of Nogo-A in Xenopus 
with oligodendrocytes and myelin similar to that in mammals. 
However,' this expression pattem in Xenopus CNS does not support the notion 
that Nogo-A a neurite outgrowth inhibitor because Xenopus capable of CNS . 
rt3generation after injury. permissive substrate property of Xenopus frog 
optic nerve was demonstrated by earlier functional assays (Lang et aI., 1995). 
Furthermore, Nogo-A is already expressed in the tadpole CNS, where both the 
ON and SC are of regeneration injury (Beattis et aI., 1990).· 
The immunostaining data of post-Iesioned nerves revealed the expression of 
Nogo-A persisted ON injury in tadpole and frog (Section 4.2.4). is 
an important finding' because Nogo-A is believed to an inhibitor for axon 
outgrowth in mammals, yet it is expressed in the regenerating nervous system of . . . 
amphibians. The expression of Nogo-A in the injured nerves were, 
however, different from those in the intact nerves. Findings revealed that more 
Nogo'-A ~xpression was found in the oligodendrocytes ~h.an in fibers. Results 
also indicated that after lesion the Nogo-A expressing cells had a similar 
morphology the myelinating oligodendrocytes found in tadpole ON. 
close association of Nogo-A with the oligodendrocyte in the regenerating nerve 
may provide an indication of the active state of oligodendrocytes. Furthermore, it 












dedifferentiation and redifferentiation, when Xenopus glia adapt the plasticity 
lesion (Lang et 1996). 
Possibility of different membrilne topology of Nogo-,A 
. In vitrQ studies ~ave demonstrated that Nogo-66is a potent inhibitory region of 
the Nogo-A protein groWth cone collapse in different models (Fournier 
. 2001). stripe from the present study have also 
demonstrated some of inhibitory effects by Nogo-66 peptide on the 
Xenopus neurons (Section 1.2). This implies that all Nogo proteins have 
inhibitory properties (Oertle et, 2003; Fournier et aL, 2001). In addition, Nogo-
A . contains a Nogo-A specific region in the N-terminal that results in potent 
neurite growth inhibition, thereby making Nogo-A the most potent inhibitor ofthe 
Nogo proteins (Chen aI., 2000; GrandPre et 2000). So far, the membrane 
topology is still not Two possible membrane· topologies of Nogo-A have 
been postulated in mammals 6.1}. When the surface expression of Nogo-A 
was studied in Xenopus oligodendrocyte cultures, the immunoreactivity of Nogo-
. A antiserum was detected permeabilisation as described in the literature 
(Klinger et ., 2004a; Taketomi et aI., 2002). This did, however, not occur in 
live-staining Nogo-A antiserum. Although one cannot neglect the possibility 
culture artifacts, these results do not indicate the in vitro surface expression of 
Nogo-A on the oligodendrocyte cultures. This controversy leads to a question 
regarding the membrane topology of Xenopus Nogo-A. One possibility is that 
Xenopus Nogo-A may exhibit a different membrane topology from that in the 
mammals and consequently it does not playa in neurite inhibition as in the 
mammalian form. Another hypothesis is that the of Xenopus Nogo-A 
is not on the plasma membrane of oligodendrocytes at hence 
of Nogo-A in the Xenopus may be not acting through contact inhibition 















Figure 6.1. The two membrane topologies for Nogo-A protein . Two putative 
transmembrane domains may span the membrane once or twice . Thus, the N-
terminus of Nogo-A may either be in cytoplasmic compartment or in extracellular / 
ER lumen space. (Adapted from Oertle and Schwab, 2003) 
Neuronal expression of Nogo-A 
In mammals, the expression of Nogo-A is not only described in oligodendrocytes 
and the myelinated tract, but in neurons as well, especially the motoneurons in 
the ventral horn of SC (Huber et ai, 2002; Hunt et ai, 2003) and the growing 
axons during nervous system development (Tozaki et aI., 2002). In Xenopus, 
immunoreactivity of Nogo-A was also found in the neurons, in particular the 
motoneurons in the ventral horn of SC and the neurons in the tadpole forebrain. 
Although these results indicate that the neuronal expression patterns of Nogo-A 
in Xenopus are similar to those in mammals, the functions of Nogo-A in neurons 
are still awaiting characterization. 
In both human and chick embryonic developmental stages where SC 
regeneration is possible, Nogo-A expression is also associated with neurons 
(O'Neill et ai, 2004). In the same study, both the Nogo-A protein and transcript 
were detected before myelination began at neurogenesis commence (O'Neill et 
ai, 2004) . Similar developmental stages were examined in the Xenopus tadpole 
SC, and indeed, the spatiotemporal expression of Nogo-A is associated with 
neurons as described in chicks and humans earlier. Based on the expression of 












postulated thatNogo-A may be a marker for growingaxons and may possibly 
promote effects axon growth (Hunt et aI., 2003; Tozaki et aL, 2002). In the 
present study, Dmn-lf~SI(m expression' of Nogo-A was found in the nerve of . 
'regenerating frog ON colocalized with the neurofilament expression in 
absence, of myelin protein (Section Due to similarity in Nogo-A 
expression between Xenopus CNS and amniotic CNS, one could hypothesize 
during development functions of Nogo-A in Xenopus and higher ' 
vertebrates neurons are likely to the same. Moreover, Nogo-A may also a 
marker for axons in Xenopus. 
Nogo and apoptosis 
When the nogo gene was initially shown to have high homology cDNA of bNI-
bovine homologue NI-250, the analysis also revealed that 
Nogo similar C-terminal domains with reticulon group of proteins 
(Chen et aI., 2000, GrandPre et aI., 2000). Nogo is thus one of the recently 
identified members of the reticulon family (Oertle aI., 2003; Oertleand Schwab, 
2003). The expression of proteins is widely found in mosteukaryotes. 
Although a role of Rtn has' been suggested in endoplasmic reticulum' (ER) 
, . 
membrane cytoskeleton Ii'nkage the network and in division, 
the functions of Rtn proteins are still poorly understood. Nonetheless, the Nogo-
AlRTN4~A has been widely described as a potent outgrowth inhibitor in 
mammals (Chen aI., 2000; et aI., 2000; Prinjha et aI., 2000). One 
could hypothesise that Nogo-AlRTN4-A may have functional 
, Rtn protein family. 
with its 
One of the Nogo spliced isoforms, Nogo-B is also known as, RTN-Xs which bind 
,to anti-apoptotic Bcl-2 family proteins, and is, likely to modulate their 
apoptotic ability. In fact, an apoptosis inducing gene (ASY) has identified to . 
be the as Nogo-B,and ectopiC expression has shown to induce 
extensive apoptosis of cancer cells (U aI., 2001). Another lirlk between the 
function of Nogo i:lnd apoptosis was implicated by the, interaction between the 
Nogo-66 ,and mitochondrial proteins" namely Nogo-interacting mitochondria 











Chapter 6 Conclusion 
complex, UQCRC1 and UQCRC2 (Hu 2002). mitochondrial proteins 
are known to part of the trigger of programmed cell death in mammalian cells. ' 
Furthermore, evidences from expressional and functional in the 
mammalian CNS have demonstrated that p7SNTR, neurotrophin receptor and 
co-receptor of NgR, mediates the cell death via Rho signaling under 
physiological and pathological conditions (Dubreuil aI., 2003; and 
1 
Thus, one could speculate that persisted expression of Nogo-A in the injured 
nerve of mammalian has a role in programmed cell death leading to the 
'failure of regeneration. On the other hand, the persisting post-lesion expression 
of Nogo-A in Xenopus could possibly mean the modulation of apoptosis after 
injury and during regeneration', However, is a high level of Nogo-A 
expression in retinal ganglion cell axons after Xenopus ON crush, and 
cells in the frog and lizard show only' relatively low levels of apoptotic death ' 
after axotomy (Lang aL, 2002; Tennant et aI., 1993). Thus, one could also 
question the connection between Nogo-A and apoptosis in Xenopus: In the 
validity of the Nogo-A isoform, Nogo-B, as a physiological pro-apoptotic protein 
has ' questioned in one of mammalian studies et aI., 2003c). 
Although more functional such as cell-count study or BrdU labeling, are 
required to demonstrate the validity of Nogo playing a role as a promoter of 
apQptosis, the link between the function Nogo and apoptosis an 
, interesting possibility. 
Mogo-Receptor expresses in Xenopus 
Hints on the possible roles of Nogo-A in Xenopus may come from the distribution 
of tl-Ie Nog066-Receptor, NgR, which, mediates the axon inhibitory 
. through binding to the Nogo-66 loop. Extensive NgR expression studi~s 
been done in mammals (Fournier 2001; Wang ai, while in lower 
vertebrates the NgR homologous gene has been identified in fish (Klinger aI., 
2004b). However, no studies have been done on amphibians to date. Although 
the Xenopus NgR sequence is yet to identified, a new polyclonal NgR 











r 6 and 
sequence across Although this new antiserum may recognize the 
,protein of interest in the Xenopus culture,' as Well as in the 
immunoblots, it is at present not specific enough to be used as a tool in further 
expression 'studies or functional This mainly due to unacceptable 
levels of non-specific binding' of pre-immune serum that has shown by 'the 
multiple intensive bands in the Western-blots. In order to obtain a more specific' 
antiserum, affinity purification can be done with the antigen, however, there can 
inherent problems with this purification due the ,use of a short as an 
antigen. The immunogenic peptide only consisted of 8 amino acids which may 
. give rise to problems due to potential cross-reactivity of the antiserum raised 
against it. Moreover, further studies such as the pre-incubation of the antiserum 
with the immunizing to carried to obtain the final proof of such 
specificity. Only once all these have been will it legitimate to 
state that this new antiserum actually NgR in Xenopus. 
Even though the mechanism behind the interaction of Xenopus NgR and Nogo-A 
is not clear, there is little doubt that NgR is present in the Xenopus, based on 
fact that Xenopus neurons are sensitive to the inhibitory influence of Nogo-A in 
vitro. It cannot be ruled' out that an intrinsic neuronal factor may modulate the 
inhibitory signal transduction in the same way intracellular molecules 
mediate the axonal growth, or overcome the inhibitory effects of the surrounding 
. environment. NgR protein was characterized as a glycosyl-phosphadidylinositol 
(GPI) anchor protein 2001) that was found to attached to the . 
plasma membrane of neurons and axons (Wong aI., 2002). Due to the nature 
of GPI-anchor of NgR which has no transmembrane domain, other membrane 
proteins have been described form a receptor complex with NgR: p7SNTR 
(Wang aI., Wong ,2002), LlNGO-1 (Mi aI., 2004) and recently 
TROYITAJ (Park et aI., 2005; Shao et I 200S). Functional studies have shown 
that the enhancement of axon regeneration is induced by manipulating the Nogo 
receptor complex (Wang et I 2002a; Wong et aI., 2002; Yamashita et aI., 2002) 
or the molecules downstream of the signal transduction cascade, such as Rho 
(Fournier et ai, 2003; Yamashita ai", 2002) cAMP (cyclic AMP) (Neumann 
et aL, 2002; Qiu et al., 2002). Furthermore, inactivation of Rho (Bertrand aI., 











6 and Conclusion 
aI., 1 Neumann et aI., 2002; Qiu et aI., 2002) lUg .... .:> the inhibition of 
axon· growth and promotes axonal. regeneration in the presence of myelin-
inhibitors. Taken together. it is possible that Xenopus neurons may 
exhibit different intrinsic properties within· the signal transduction or the Nogo . 
receptor complex in which the Xenopus homologue has also been identified 
(Hutson Bothwell. 2001). However. the of inhibitory activity cannot be 
explained by the absence of NgR as receptor is most likely also expressed in 
Xenopus as shown by study. 
6.2 Conclusion 
inhibitory activity of TN-R and Nogo-A towards neurite outgrowth 
shown in in vitro studies of mammalian cells. Thus, it could be responsible 




immunohistochemical experiments of this study. it is clear that putative 
neurite growth inhibitory proteins, Nogo-A TN-R are expressed in the 
amphibian which can perform axonal regeneration after injury. The 
patterns TN-R and Nogo-A in Xenopus CNS was found to 
associated with myelin and oligodendrocytes.· This is in line with published 
findings the mammalian CNS, suggesting their roles in myelination and 
oligodendrocyte functions. In addition, expression of proteins was also 
observed in neurons, to mammals. Conflicting with their postulated role in 
inhibition of axon growth, however, both molecules were present at the injury site 
of ON, which can be regenerated in Xenopus. post-lesion expression 
patterns of TN-R and Nogo-A could imply a role in oligodendrocytes 
dedifferentiation and redifferentiation. Moreover, the outgrowth cultured 
Xenopus neurons was not cornpletely inhibited by the TN-R and Nogo-A. Thus, 
TN-R proteins from different classes of vertebrates might differ in their ability 
to inhibit axon growth. 
In conclusion, results not provide evidence of a correlation between the 











c 6 Discussion Conclusion 
for axon regeneration in ttle of Xenopus. One could argue there is an 
intrinsic difference in neuron properties amphibians and the 
mammals. Alternatively, TN-R and Nogo-A may exhibit different functions 
development, adulthood and regeneration in .'t'I'" .. ·", .... t vertebrate classes .. 
6.3 Future Work 
Although TN-R and Nogo-A are known potent neurite outgrowth inhibitors, other 
functions are yet to be discovered that to future 
• An investigation on the origin of the protein synthesis may provide an 
indication of and how the proteins are synthesized. This can be 
achieved by considering mRNA expression in TN-R- and Nogo-A-
expressing such as in situ hybridization. It will also interesting 
measure the messenger of the signal transduction in an attempt to 
understand the change in the intrinsic neuronal. 
• Normally, the transgenic or knock-out animals are the· models· for 
discovering the functions of a protein. It is, however, technically challenging 
to perform such experiments in Xenopus . . To reveal the yet unknown 
. functions of these proteins, various in vivo and in vitro analyses of TN-R and 
Nogo-A can performed in this regenerating system. For instance, RNA- . 
interference technique can performed at embryonic of the 
animal, or the application of function-blocking antibodies can be done the 
in vivo or in vitro models. Another of functional study will 
intravital microscopic imaging and analysis of axon growth 
under physiological and pathological conditions. 
guidance 
Only with clarity on the functions of .and Nogo-A it will be possible 
to assess the correlation between the expression of these proteins and the 
regenerating ability among the different classes of vertebrates and thus shed 
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Phylogenetic analysis of tenascin-R the tI~r,r~njencp eNS 
1. Vertebrate species (brai'ntissue) analyzed by Western blotting: 
Squalus _~~u.u ...... " 
Cyprinus (trout). Carassius aureus 
Triturus cristatus (newt), Salamandra (salamander), Rana ridibunda (frog) 
Natrix natrix (water snake), Lacerta viridis (lizard), 
Galus domesticus (chick), Columba livia (pigeon) 
f'lpor1Tl!lnnl (tortoise) 
Erinaceus ~oncolor (hedgehog), Spermopnilus citellus, Mus (Mus musculus, Microtus 
Apodemus fl.), Rattus (rat), Oryctolagus cuniculus (rabbit), Bos (cattle), Sus scrofa (pig), 
Homo sapiens (man) 
TN-R forms'" tn-R! tn-R6 pTN-R 
Squalus 200-220 k:D + + + + 
Cyprinus, others 170kD + + + + 
Salarnandra, Rana 180-160 kD + + + ? + + 
. Natrix, others 160-180 kD + + + ? + + 
Galus 180-160 kD + + + + + + + 
160-180 kD + + + +. + + + 
Homo sapiens 160-180 kD + + + + + + + 
>II Major molecular forms detectable; the order of reflects the predominant 
TN-R 160 ot TN-R ISO 
2. Polyclonal (pTN.R) and monoclonal antibodies tn-RI-6 to TN-R 
Antibody Species [cOile;] Immunoblot (EeL) Immunocytochemistry 
1. pTN-R rabbit 4.2 mglml 1:2000 - 1:5000 1:500-1:1000 
mouse IgG 2.0 mglml 1:1000 - 1:2000 1:300 - 1:700 
3. tn-R2 mouse IgG 3.0 1:1000- 1:3000 1:100 - 1:500 
4. tn-R4'" mouse 4.0 mglml 1:1000 - 1:2000 1:500 - 1:2000 
5. tn·R6'" mouse IgG 4.S mglml 1:1000 - 1:3000 1:500 ~ 1:2000 
All antibodies represent affinity purified IgG fractions (1 ml 
'" most suitable for immunocytochemistry 












I, Undersigned JJiillgnC)stllcs Inti. Inc., located at 5415 Lost San 
is a Drug Agepcy (USDA) and 
periodically inspected animal T",,,,,,,,,,,,:n facility (USDA 40.) An antllbo(i1eS 
our own healthy ... ,u"".., .. that. have 
no clinical of any .... ''''''''.'u .. " UllSl;;A,)t~lii, In addition, the antibodies have affinity 
The material with shipment is strictly for ="~':"::::"===~~=!.,l..' 
it is not use in or The supplied ",<l't .. "';",1 
health to the ..... r"l'\~tn .. 1 or with the 
5415 Lost Lane " San Antonio .. TX USA .. (800) 786-5777 .. (210) 5 .. Fax 561·9544 












Name of peptide: 
supplied in: 
Amount of peptide Coupled: 
Concentration: 
Volume: 










Soluble in DMSO 
GLUT 
Recommended Storage tor peptide-Conjugate: 4°C for short 
peptide-conjugate may be cloudy appearance upon Unr.,.ap before use. 
This does not affect the antigenicity of the " ...... "''''c<>f'' 
Please note that no preservative was added to the ""'''~j,I!:>''''''' 
COIuu!l~ate will used for purposes. 
ped. and Chec~ed by: 
/./.;J.~ 
;;/' Date:/6sIOlIOS 
54i5 Lost Lane .. SanAntonio" TX78238,USA" (800)786-5777 to (210)" Fax(210) 
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Data Sheet of Synthetic NgR Peptide 
Home Of Custom Peptfdes And Antibodies - We 00 More for Less! 
5415 Lost San Antonio, TX 78238,'if (800) (210) Fax: 561-9544 
Web Site: www.4adLcom 
To ensure that our material retain their the following 
',0 determlfl6 the Sllitable methoo of dissOilliOg your peptlde. 
utilize only a smalt amount of appropriate solvents. Dissolve 
the peptide in Distilled or deionized sterile (and if possible, 
oxygen free) water. Only when the peptide has been fully 
dissolved should required buffer salts/solution be added and 
the solution diluted to its final concentration, that is, dissolve 
the pepiide first and add the buffer afterwards. 
rlo,,,,,,,rt,,'li,,n can occur in peptide solutions. Always 
peptides. If reqUired, the peptide 
solutions may be fillered a 0.45 um or 0.2 um filter. 
Do not keep peptide solutions at room temp. 
Amino acids such as cysteine, Methionine or 
susceptible to oxidation and should be dissolved In 
oxygen free water. This may be by degassing under 
reduced pressure by sparing an inert gas such as 
Nitrogen, Helium or Argon. 
is insoluble in water. son.ication 
OrE!aKmll up any particles increase the rate of UO,,"UIUlIIVI 
Caution: Sonication can cause warming of the solution and 
degradation oUhe peptide. 
If the peptide contains many basic amino acids (K, R etc), use 
an aqueous acetic acid solution (1 to 10%) with or without 
'SOnication. For very hydrophobic peptides, use 50% aqueous 
acetic acid. 
If the peptide has many acidic amino acids (E, 0 use an 
aqueous ammonia solution (1 to 10%) or a volatile buffer 
(up to pH 8) such as N-Elhymorpholine Acetic or Bicarbonate 
with or without sonicaton. The pH may have to be adjusted 
before chromatography. 
be used to dissolve some medium 
is fo be injected onto a column, 
the amount of organic especially must be 
kept small, or retention time will be greatly 
is highly hydrophobic with aromatic or 
side chains, such as Val, Leu, lie, Met, Phe, 
Ala or if the peptide is neutral, use a chaotropic agent 
as DMFIOM$O-
a) High concentration of chaolropic salts 10 
the peptide by breaking the secondary stnurlt,n.,; 
b) Chaotropic ag"nts afe for orena,";no solution 
for analysis, but may interfere 
system used for study of the peptide 
All. 
at 
are suggesled for and use. 
c. are DMF or DMSO. (up to 
30%) until the peptide djssolves~ 
d. On reverse phase chromatography, the DMF 
will elute with the buffer front. The peal< cao 
be vary high, depending on how much was 
injected. Most are retained 
than the few it takes for a large 
to elute~ If the peptide is very small and 
the starting % have 10 be 
dE!(~relaSil,d when the peptide is 
should be stored refrigerated, preferably 
maximum stability. Most peptides when 
stored -20°C will remain stable for several 
mOl'lths. applies to many amino acid derivatives, 
lipids, and other proteins as wall as 
peptides. exception to this .Is immobilized 
proteins and 1''''1"''''''''''. 
a refrigerated product, the bottle or the 
vial allowed to warm to room in a 
desiccators containing fresh desiccant 
opening. From ·20 "C this can take an hour or more, 
depending on tM pack size. Failure to do this can 
cause condensalio.n 10 form on the W)lhen the 
bottle or vial is and will reduce the 
of the Once opened, required 
should be out to prevent water 
This is a problem with some 
hv(irQl~coolc pepiides. 
Peptide in s'Olulion are much less stable Ihan 
lyophilized peptides. FOr best result please follow the 
foliowing guidelines. 
1. Avoid repeated It is 
recommenl.ied that be.aliquoted 
ThliiW only What is needed: DO not store diluted 
Solutions .. 
2. For maximum stability, store at -20°C in a 
sterile, pH 5 to 7 buffered solution. 
3. Amino aCid such as Cysteine, Methionine or 
Tryptophan are susceptible to oxidation and 
shou·ld be dissOlved/stored in free water. 
4. aaeterial contaminatioh poeptides. so 
use sterile water or buffer. 
Peptide raeon 40107 
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